Heterocycle-substituted, n-phenyl-phthalamide derivatives, related compounds and their use as insecticides

ABSTRACT

Novel benzenedicarboxamides of the formula (I) wherein X represents hydrogen, halogen atom, nitro, C 1-6 alkylsulfonyloxy, C 1-6 alkylsulfinyl, C 1-6 alkylsulfenyl or C 1-6 alkylsulfonyl, R 1  represents C 1-6 alkyl, C 1-6 alkylthio-C 1-6 alkyl, C 1-6 alkylsulfinyl-C 1-6 alkyl or C 1-6  alkylsulfonyl-C 1-6 alkyl, Y represents halogen or C 1-6 alkyl, m represents 0 or 1, A represents O, S, SO, SO 2 , CH 2  or CH(CH 3 ), and Q represents a 5- or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted; processes for their preparation, their intermediates and their use as insecticides.

The present invention relates to novel benzenedicarboxamides, processes for the preparation thereof, their intermediates and their use as insecticides.

It was already known that phthalamide derivatives are useful as insecticides [see JP-A 11-240857 (1999), JP-A 2001-64258, JP-A 2001-64268, JP-A 2001-131141, JP-A 2003-40864, WO 01/21576 and WO 03/11028], and also that they show medicinal function [see JP-A 59-163353 (1984)].

There have now been found novel benzenedicarboxamides of the formula (I)

wherein

-   X represents hydrogen, halogen atom, nitro, C₁₋₆alkylsulfonyloxy,     C₁₋₆alkylsulfinyl, sulfenyl or C₁₋₆alkylsulfonyl,     -   R¹ represents C₁₋₆alkyl, C₁₋₆alkylsulfinyl-C₁₋₆alkyl or C₁₋₄         alkylsulfonyl-C₁₋₆alkyl, -   Y represents halogen or C₁₋₆alkyl, -   m represents 0 or 1, -   A represents O, S, SO, SO₂, CH₂ or CH(CH₃), and -   Q represents a 5- or 6-membered heterocyclic group that contains at     least one hetero atom selected from the group consisting of N, O and     S and can be optionally substituted.

The compounds of the formula (I), according to the invention, can be obtained by

-   (a) reacting compounds of the formula (II)

-   -   wherein R¹ and X have the same definitions as aforementioned,     -   with compounds of the formula (III)

-   -   wherein Y, A, m and Q have the same definitions as         aforementioned,     -   in the presence of inert solvents, and if appropriate in the         presence of an acid catalyst,         or

-   (b) reacting compounds of the formula (IV)

-   -   wherein X, Y, A, m and Q have the same definitions as         aforementioned,     -   with compounds of the formula (V)

H₂N—R¹  (V)

-   -   wherein R¹ has the same definitions as aforementioned,     -   in the presence of inert solvents, and if appropriate in the         presence of an acid catalyst,         or

-   (c) reacting compounds of the formula (VI)

-   -   wherein X and R¹ have the same definitions as aforementioned,     -   with the compounds of the formula (III),

-   -   wherein Y, A, m and Q have the same definitions as         aforementioned,     -   in the presence of inert solvents, and if appropriate in the         presence of an acid catalyst,         or

-   (d) reacting compounds of the formula (VII)

-   -   wherein X, Y, A, m and Q have the same definitions as         aforementioned,     -   with the compounds of the formula (V),

H₂N—R¹  (V)

-   -   wherein R¹ has the same definitions as aforementioned,     -   in the presence of inert solvents, and if appropriate in the         presence of an acid catalyst,         or

-   (e) compounds of the formula (VIII)

-   -   wherein X, Y, A, in and Q have the same definitions as         aforementioned,     -   are reacted with the compounds of the formula (V),

H₂N—R¹  (V)

-   -   wherein R¹ has the same definitions as aforementioned,     -   in the presence of inert solvents, and if appropriate in the         presence of an acid catalyst,         or

-   (f) in the case that R¹ represents C₁₋₆alkylsulfinyl-C₁₋₆alkyl or     C₁₋₆alkylsulfonyl-C₁₋₆alkyl in the formula (I), reacting compounds     of the formula (If)

-   -   wherein     -   R^(1f) represents C₁₋₆alkylthio-C₁₋₆alkyl, and     -   X, Y, A, in and Q have the same definitions as aforementioned,     -   with an oxidizing agent in the presence of inert solvents.

According to the present invention, the benzenedicarboxamides of the formula (I) show a strong insecticidal action.

The compounds of the formula (I) are conceptually embraced in the general formula described in the aforementioned JP-A 11-240857 (1999). But they are not specifically disclosed at all in it and new compounds. Surprisingly, they show particularly remarkable insecticidal action compared with similar compounds described in the known prior art.

In the present specification:

“Halogen” represents fluorine, chlorine, bromine and iodine, and preferably represents fluorine, chlorine and bromine.

“Alkyl” represents straight chain or branched chain C₁₋₁₂alkyl, for example, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, n-pentyl, n-hexyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, etc. and preferably represents C₁₋₆alkyl.

As each alkyl part in “alkylsulfonyloxy”, “alkylsulfenyl”, “alkylthioalkyl”, “alkylsulfinylalkyl”, “alkylsulfonylalkyl”, “alkoxy”, “alkylthio”, “alkylsulfinyl”, “alkylsulfonyl”, “haloalkyl”, “haloalkoxy”, “haloalkylthio”, “haloalkylsulfinyl”, “haloalkylsulfonyl” and “haloalkylcarbonyl”, there can be mentioned the same as described in the above-mentioned “alkyl” as examples.

As each halogen part in “haloalkyl”, “haloalkoxy”, “haloalkylthio”, “haloalkylsulfinyl”, “haloalkylsulfonyl” and “haloalkylcarbonyl”, there can be mentioned the same as described in the above-mentioned “halogen” as examples.

“5- or 6-membered heterocyclic group” contains at least one hetero atom selected from the group consisting of N, O and S, and preferably represents a heterocyclic group containing “one to three N atoms”, or “one O atom”, or “one S atom”, or “both one S atom and one to two N atoms”, or “both one O atom and one to two N atoms”, and as specific examples thereof, pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl, furyl, thienyl, oxadiazolyl and pyrimidinyl, and moreover as most preferable examples thereof, pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl, oxadiazolyl and pyrimidinyl are exemplified.

In the compounds of the formula (I), according to the invention, the compounds in case that

-   X represents hydrogen, fluorine, chlorine, bromine, iodine, nitro,     C₁₋₄ alkylsulfonyloxy, C₁₋₄alkylsulfinyl, C₁₋₄ alkylsulfenyl or C₁₋₄     alkylsulfonyl, -   R¹ represents C₁₋₄alkyl, C₁₋₄alkylthio-C₁₋₄alkyl,     C₁₋₄alkylsulfinyl-C₁₋₄alkyl or C₁₋₄alkylsulfonyl-C₁₋₄alkyl, -   Y represents fluorine, chlorine, bromine or C₁₋₄alkyl, -   m represents 0 or 1, -   A represents O, S, SO, SO₂, CH₂ or CH(CH₃), and -   Q represents 5-membered or 6-membered heterocyclic group that     contains at least one hetero atom selected from a group consisting     of N, O and S and can be optionally substituted by at least one     selected from a group consisting of C₁₋₆alkyl, C₁₋₆alkoxy,     C₁₋₆alkylthio, C₁₋₆alkylsulfinyl, C₁₋₆alkylsulfonyl,     C₁₋₁₀haloalkoxy, C₁₋₆haloalkoxy, C₁₋₆haloalkylthio,     C₁₋₆haloalkylsulfinyl, C₁₋₆haloalkylsulfonyl, C₁₋₆haloalkylcarbonyl,     halogen, oxo and hydroxy group, can be mentioned as preferable.

Above all, in the compounds of the formula (I), the compounds in case that

-   X represents hydrogen, fluorine, chlorine, bromine, iodine, nitro,     methanesulfonyloxy, C₁₋₂ alkylsulfenyl or C₁₋₂ alkylsulfonyl, -   R¹ represents isopropyl, C₁₋₂alkylthio-C₃₋₄alkyl,     C₁₋₂alkylsulfinyl-C₃₋₄alkyl or C₁₋₂alkylsulfonyl-C₃₋₄alkyl, -   Y represents fluorine, chlorine or methyl, -   m represents 0 or 1, -   A represents O, S, SO, SO₂, CH₂ or CH(CH₃), and -   Q represents heterocyclic group, selected from a group consisting of     pyrazolyl, triazolyl, pyrazolinyl, imidazolyl, thiazolyl, pyrrolyl,     oxadiazolyl and pyrimidinyl, that can be optionally substituted by     at least one selected from the group consisting of C₁₋₄alkyl,     C₁₋₄alkoxyl, C₁₋₄alkylthio, C₁₋₄alkylsulfinyl, C₁₋₄alkylsulfonyl,     C₁₋₈haloalkyl, C₁₋₄haloalkoxy, C₁₋₄haloalkylthio,     C₁₋₄haloalkylsulfinyl, C₁₋₄haloalkylsulfonyl, C₁₋₄haloalkylcarbonyl,     fluorine, chlorine, bromine, iodine, oxo and hydroxy group,     are particularly preferable.

The compounds of the formula (I), according to the present invention, include stereo isomers (R/S configuration) in case that the group R¹ has an asymmetric carbon.

The aforementioned process (a) can be illustrated by the following reaction scheme in case that, for example, 3-(1,1-dimethyl-2-methylthioethylimino)-4-iodo-3H-isobenzofuran-1-one and 1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole are used as starting materials.

The aforementioned preparation process (b) can be illustrated by the following reaction scheme in case that, for example, 2-{4-[3,5-bis(trifluoromethyl)pyrazole-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindole-1,3-dione and (S)-1-methyl-2-methylthioethylamine are used as starting materials.

The aforementioned preparation process (c) can be illustrated by the following reaction scheme in case that, for example, 3-iodo-N-(1,1-dimethyl-2-methylthioethyl)-phthalamic acid and 2-methyl-4-[1-(3-trifluoromethylpyrazole-1-yl)-ethyl]aniline are used as starting materials.

The aforementioned preparation process (d) can be illustrated by the following reaction scheme in case that, for example, 1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-(1,2,4)-triazol and 1-methyl-2-methylthioethylamine are used as starting materials.

The aforementioned preparation process (e) can be illustrated by the following reaction scheme in case that, for example, N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methyl-phenyl}-6-iodo-phthalamic acid and 1-methyl-2-methylthioethylamine are used as starting materials.

The aforementioned process (f) can be illustrated by the following reaction scheme in case that, for example, N²-(1-methyl-2-methylthioethyl)-3-iodo-N¹-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]phenyl}phthalamide and m-chloroperbenzoic acid are used as starting materials.

The compounds of the formula (II), used as starting materials in the above-mentioned preparation process (a), are per se known compounds and can be easily prepared according to the process described in, for example, JP-A 11-240857 (1999), JP-A 2001-131141.

As specific examples of the compounds of the formula (Ia), used as starting materials in the preparation process (a), there can be mentioned the following:

-   3-isopropylimino-3H-isobenzofuran-1-one, -   4-fluoro-3-isopropylimino-3H-isobenzofuran-1-one, -   4-chloro-3-isopropylimino-3H-isobenzofuran-1-one, -   4-bromo-3-isopropylimino-3H-isobenzofuran-1-one, -   4-iodo-3-isopropylimino-3H-isobenzofuran-1-one, -   3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   4-fluoro-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   4-chloro-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   4-bromo-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   4-iodo-3-(1-methyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-4-fluoro-3H-isobenzofuran-1-one, -   4-chloro-3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   4-bromo-3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-3H-isobenzofuran-1-one, -   3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-4-iodo-3H-isobenzofuran-1-one, -   3-isopropylimino-1-oxo-1,3-dihydro-isobenzofuran-4-yl     methanesulfonate -   3-(1-methyl-2-methylsulfanyl-ethylimino)-1-oxo-1,3-dihydro-isobenzofuran-4-yl     methanesulfonate -   3-(1,1-dimethyl-2-methylsulfanyl-ethylimino)-1-oxo-1,3-dihydro-isobenzofuran-4-yl     methanesulfonate and so on.

The compounds of the formula (III), used as starting materials in the above-mentioned preparation process (a), which are partly novel compounds that are not described in the existing literature yet, can be obtained, for example, by reducing compounds of the formula (IX)

wherein Y, A, m and Q have the same definitions as aforementioned, according to the catalytic hydrogen reduction process, a well-known process in the field of organic chemistry, with hydrogen in the presence of a catalytic reduction catalyst, for example, palladium carbon, Raney nickel, platinum oxide, etc.

The above-mentioned catalytic hydrogen reduction process can be conducted in an adequate diluent.

As examples of the diluent used in that case there can be mentioned ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, tetrahydrofuran (THF), etc.; alcohols, for example, methanol, ethanol, isopropanol, butanol, ethylene glycol, etc. and as catalytic reduction catalyst there can be mentioned, palladium carbon, Raney nickel, platinum oxide, etc.

The reaction can be conducted at the temperatures generally from about 0 to about 100° C., preferably from room temperature (20° C.) to about 80° C.

Said reaction can be conducted usually under normal pressure but can be operated optionally also under elevated pressure.

For example, a compound of the formula (III) can be obtained by hydrogenating the compounds of the formula (IX) in a diluent, for example, ethanol, in the presence of 0.1-10% (w/w) palladium carbon.

Also by a reduction reaction using metals etc. instead of catalytic hydrogen reduction, the compounds of the formula (III) can be obtained from the compounds of the formula (IX).

As a reduction process using metals etc., there can be mentioned, for example, a process of reacting iron powder in acetic acid, a process of reacting zinc dust under neutral condition (Organic Syntheses Collective Vol. II, p. 447), a process of reacting stannic chloride under acidic condition (Organic Syntheses Collective Vol. II, p. 254), a process of reacting titanium trichloride under neutral condition, etc.

The compounds of the formula (IX) are novel compounds and can be obtained by reacting the compounds of the formula (IX) wherein A represents other than oxygen atom, for example, compounds of the formula (X)

wherein

-   Y and m have the same definitions as aforementioned, -   A¹ represents S, SO, SO₂, CH₂ or CH(CH₃), and -   M represents chlorine, bromine or methanesulfonyloxy,     with compounds of the formula (XI)

H-Q  (XI)

wherein Q has the same definition as aforementioned.

The compounds of the formula (X), are well known in the field of organic chemistry and described in publications, for example, Chem. Abstr., Vol. 58, 3444e (1963); Bull. Soc. Claim. Fr. (1934), p. 539-545; J. Chem. Res. Miniprint, Vol. 8 (1987), p. 2133-2139; J. Chem. Soc. B (1967), p. 1154-1158; J. Chem. Soc. (1961), p. 221-222; J. Amer. Chem. Soc., Vol. 111 (1989), p. 5880-5886; J. Amer. Chem. Soc., Vol. 96 (1974), p. 7770-7781; Can. J. Chem., Vol. 68 (1990), p. 1450-1455, Tetrahedron Letter, vol. 35 (1994), p. 7391-7394.

As specific examples of the compounds of the formula (X), there can be mentioned specifically

-   2-methyl-4-nitrobenzyl chloride, -   3-methyl-4-nitrobenzyl chloride -   4-nitrobenzyl methanesulfonate -   2-methyl-4-nitrobenzyl methanesulfonate -   3-methyl-4-nitrobenzyl methanesulfonate, -   4-nitrobenzenesulfenyl chloride, -   4-nitrobenzenesulfinyl chloride, -   4-nitrobenzenesulfonyl chloride, -   4-nitro-3-methylbenzenesulfonyl chloride, -   3-fluoro-4-nitrobenzyl bromide, -   3-chloro-4-nitrobenzyl chloride and so on.

The nitro-substituted benzoic acids and their esters, starting materials of the compounds of the formula (X), are known compounds described in, for example, Chem. Ber., Vol. 52 (1919), p. 1083; Bull. Soc. Chim. Fr. (1962), p. 2255-2261; Tetrahedron (1985), p. 115-118; Chem. Pharm. Bull., Vol. 41 (1993), p. 894-906; WO 2001/042227.

The compounds of the formula (XI) include known compounds and as their specific examples, there can be mentioned:

-   3,5-bis(trifluoromethyl)-1H-pyrazole, -   5-difluoromethoxy-3-trifluoromethyl-1H-pyrazole, -   4-pentafluoroethyl-1H-pyrazole, -   5-hexafluoro-n-propyl-1H-pyrazole, -   3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazole, -   5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole, -   5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4) triazole, -   5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazole, -   2,4-bis(trifluoromethyl)-1H-imidazole, -   3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1,2-dihydro-(1,3,4)-triazol-2-one, -   2,5-bis(trifluoromethyl)-(1,3,4)-triazole, -   5-pentafluoroethyl-1H-pyrazole, -   3-pentafluoroethyl-1H-pyrazole, -   4-bromo-3-trifluoromethyl-1H-pyrazole, -   3-trifluoromethyl-1H-pyrazole, -   5-(difluoromethyl)-1,2-dihydro-2-methyl-3H-(1,2,4)-triazol-3-one, -   4-(trifluoromethyl)-2H-1,2,3-triazole, -   4-iodo-3-pentafluoroethyl-1H-pyrazole, -   3-pentafluoroethyl-4-(1,1,2,2-tetrafluoroethyl)-1H-pyrazole, -   3,4-bis-pentafluoroethyl-1H-pyrazole, -   3,5-diiodo-4-methyl-1H-pyrazole, -   3-Heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole, -   3,5-bis(pentafluoroethyl)-1H-(1,2,4)-triazole and so on.

The above-mentioned reaction of the compounds of the formula (X) with the compounds of the formula (XI) can be conducted in an adequate diluent.

As examples of the diluent used in that case there can be mentioned, for example, aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.

The reaction can be conducted in the presence of an acid binder and as said acid binder there can be mentioned, for example, as inorganic base, hydrides, hydroxides, carbonates, bicarbonates, etc. of alkali metals or alkaline earth metals, for example, sodium hydride, lithium hydride, sodium hydrogen carbonate, potassium hydrogen carbonate, sodium carbonate, potassium carbonate, lithium hydroxide, sodium hydroxide, potassium hydroxide, calcium hydroxide, etc.; inorganic alkali metal amides, for example, lithium amide, sodium amide, potassium amide, etc.; as organic base, alcoholates, tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO), 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.

The above-mentioned reaction can also be conducted by a process using a phase transfer catalyst in the presence of a diluent. As examples of the diluent used in that case there can be mentioned water; aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran diethylene glycol dimethyl ether (DGM), etc. As examples of the phase transfer catalyst, quaternary ions, for example, tetramethylammonium bromide, tetrapropylammonium bromide, tetrabutylammonium bromide, tetrabutylammonium bissulfate, tetrabutylammonium iodide, trioctylmethylammonium chloride, benzyltriethylammonium bromide, butylpyridinium bromide, heptylpyridinium bromide, benzyltriethylammonium chloride, etc.; crown ethers, for example, dibenzo-18-crown-6, dicyclohexyl-18-crown-6, 18-crown-6, etc.; cryptands, for example, [2.2.2]-cryptate, [2.1.1]-cryptate, [2.2.1]-cryptate, [2.2.B]-cryptate, [3.2.2]-cryptate, etc.

The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about 0 to about 200° C., preferably from room temperature (20° C.) to about 150° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the above-mentioned reaction, the aimed compounds of the formula (IX) can be obtained, for example, by reacting 1 mole to a little excess mole amount of the compounds of the formula (XI) to 1 mole of the compounds of the formula (X) in a diluent, for example, DMF, in the presence of potassium carbonate.

As the compounds of the formula (IX) obtained according to the above-mentioned process, there can be mentioned, for example, the corresponding 4-nitrobenzyl derivatives to the 4-aminobenzyl derivatives of the formula (III) mentioned hereinafter. And, as one typical example, 1-(3-methyl-4-nitrobenzyl)-3,5-bis-(trifluoromethyl)-1H-pyrazole can be mentioned.

Furthermore, in a case where Q represents 2-thiazolyl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrobenzyl)-4-pentafluoroethyl-thiazole can be prepared by the following way in which a known compound, 3-methyl-4-niirobenzylcyanide (see J. Chem. Soc., vol. 97 (1910), p. 2260) is reacted with hydrogen sulfide, and then the product, 3-methyl-4-nitro-benzylthioamide is reacted with a commercial product, 1-bromo-3,3,4,4,4-pentafluoro-2-butanone and then cyclized, according to a method described in J. Heterocycl. Chem., vol. 28 (1991) p. 907 to 911.

In a case where Q represents 1,3,4-oxadiazol-2-yl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,3,4-oxazole can easily be obtained, according to a method described in Heterocycles, (1994), vol. 38, p. 981 to 990, from the corresponding aldoxime as a starting material which can be prepared by a method described in Justus Liebigs Ann. Chem., (1927) vol. 45, p. 166.

And, as another specific example, 2-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,3,4-oxazole can easily be obtained, according to a method described in Heterocycles, (1994) vol. 38, p. 981 to 990, from the corresponding 3-methyl-4-nitrobenzaldehyde oxime. In the above preparation, the oxime can be obtained from a known 3-methyl-4-nitrobenzaldehyde [see J. Chem. Soc. B, (1967) p. 1154 to 1158] as a starting material, according to methods described in J. Chem. Soc. C, (1969) p. 986 to 990 and then Tetrahedron Letter, vol. 35 (1994) p. 9099 to 9100.

In a case where Q represents 2H-1,2,3-triazol-2-yl in the formula (IX), as a specific example, 2-(3-methyl-4-nitrobenzyl)-2H-4-trifluoromethyl-1,2,3-triazole can easily be prepared by a reaction of a known 3-methyl-4-nitrobenzyl chloride with a known 2H-4-trifluoromethyl-1,2,3-triazole described in J. Chem. Soc., Perkin Transaction 2, vol. 10 (1989) p. 1355 to 1375.

In a case where Q represents 1H-1,2,4-triazol-1-yl in the formula (IX), as a specific example, 5-(3-methyl-4-nitrophenylsulfanyl)-1-methyl-3-trifluoromethyl-1H-1,2,4-triazole can easily be prepared by a reaction of 1-fluoro-3-methyl-4-nitrobenzene with a known 5-mercapto-1-methyl-3-trifluoromethyl-1H-1,2,4-triazole described in J. Med. Chem., vol. 35 (1992) p. 2103 to 2112, according to the same preparation as Synthesis Example 47 hereinafter.

In a case where Q represents 1,2,4-oxazol-3-yl in the formula (IX), as a specific example, 3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,2,4-oxazole can easily be obtained from 3-methyl-4-nitrobenzamideoxime, according to a method described in 3. Org. Chem., vol. 68(2), 2003, p. 605-608. And, 3-methyl-4-nitrobenzamideoxime can be prepared by a reaction of a commercial 3-methyl-4-nitrobenzonitrile with hydroxylamine, according to a method described in Chem. Ber., vol. 22 (1889), p. 2428.

And, as another specific example, 3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,2,4-oxazole can easily be obtained from 2-(3-methyl-4-nitrophenyl)-acetamideoxime as well, according to a method described in J. Org. Chem., vol. 68(2), 2003, p. 605-608. And, 2-(3-methyl-4-nitrophenyl)-acetamideoxime can be prepared by a reaction of 3-methyl-4-nitrophenyl-acetonitrile with hydroxylamine, according to a method described in Chem. Ber., vol. 22 (1889), p. 2428.

In a case where Q represents 1H-1,2,4-triazol-3-yl in the formula (IX), as specific examples, 1-methyl-3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1H-1,2,4-triazole can easily be prepared by a reaction of the above 3-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1,2,4-oxazole with methylhydrazine, according to a method described in J. Org. Chem., vol. 68(2), 2003, p. 605-608, and also 1-methyl-3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1H-1,2,4-thiazole can be done by a reaction of the above 3-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1,2,4-oxazole with methylhydrazine as well.

The compounds of the formula (IX) can be prepared, besides the above-mentioned preparation process, also by the process to be mentioned later in Examples as an alternative.

As specific examples of the compounds of the formula (III) there can be mentioned, for example, the following:

-   1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-5-difluoromethoxy-3-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-4-pentafluoroethyl-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-5-hexafluoro-n-propyl-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazole, -   1-(4-amino-3-methylbenzyl)-5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole, -   1-(4-amino-3-methylbenzyl)-5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4)-triazole, -   4-(4-amino-3-methylbenzyl)-5-difluoromethoxy-1-difluoromethyl-3-trifluoromethyl-1H-pyrazole, -   4-(4-amino-3-methylbenzyl)-3-difluoromethoxy-1-difluoromethyl-5-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazole, -   1-(4-amino-3-methylbenzyl)-2,4-bis(trifluoromethyl)-1H-imidazole, -   4-(4-amino-3-methylbenzyl)-2-(2,2,2-trifluoroethyl)-5-trifluoromethyl-2,4-dihydro-3H-(1,2,4)-triazol-3-one, -   2-(4-amino-3-methylbenzyl)-4-(2,2,2-trifluoroethyl)-5-trifluoromethyl-2,4-dihydro-3H-(1,2,4)-triazol-3-one, -   1-(4-amino-3-methylbenzyl)-2,5-bis(trifluoromethyl)-1,3,4-triazole, -   2-(4-amino-3-methylbenzyl)-4,6-bis(trifluoromethyl)-pyrimidine, -   2-(4-amino-3-methylphenoxy)-4,6-bis(trifluoromethyl)-pyrimidine, -   1-(4-amino-3-methylphenyl)-3,5-bis(trifluoromethyl)-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-5-pentafluoroethyl-1H-pyrazole, -   1-(4-amino-3,7-methylphenyl)-3-pentafluoroethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-4-pentafluoroethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-3-methyl-5-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-5-methyl-3-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-4-bromo-3-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-3-trifluoromethyl-1H-pyrazole, -   1-(4-amino-3-methylphenyl)-5-hydroxy-3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1H-4,5-dihydropyrazole, -   5-(4-amino-3-methylphenyl)-1-(2,2,2-trifluoroethyl)-3-trifluoromethyl-pyrazole, -   5-(4-amino-3-methylphenyl)-1-difluoromethyl-3-trifluoromethyl-pyrazole, -   3-(4-amino-3-methylphenyl)-1-difluoromethyl-3-difluoromethoxy-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,4-bis(pentafluoroethyl)-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoroethyl)-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,4-bis(pentafluoropropyl)-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoropropyl)-1H-pyrazole, -   1-(4-amino-3-methylbenzyl)-3,5-bis(pentafluoroethyl)-1H-(1,2,4)-triazole, -   1-(4-amino-3-methylbenzyl)-2,5-bis(pentafluoroethyl)-1H-(1,3,4)-triazole, -   2-(4-amino-3-methylphenyl)-5-(trifluoromethyl)-1,3,4-oxadiazole, -   2-(4-amino-3-methylphenyl)-5-(pentafluoroethyl)-1,3,4-oxadiazole, -   2-(4-amino-3-methylphenyl)-5-(heptafluoropropyl)-1,3,4-oxadiazole, -   2-(4-amino-3-methylbenzyl)-5-(trifluoromethyl)-1,3,4-oxadiazole, -   2-(4-amino-3-methylbenzyl)-4-(trifluoromethyl)-2H-1,2,3-triazole, -   2-(4-amino-3-methylbenzyl)-4-(pentafluoroethyl)-thiazole, -   5-(4-amino-3-methylphenyl)sulfanyl-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole, -   3-(4-amino-3-methylphenyl)-5-(trifluoromethyl)-1,2,4-oxadiazole, -   3-(4-amino-3-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-1,2,4-triazole, -   1-(4-amino-3-chlorobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole, -   1-(4-amino-3-fluorobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole and     so on.

The compounds of the formula (IV), used as starting materials in the above-mentioned preparation process (b), are novel compounds and can be easily obtained according to the process described in Japanese Laid-open Patent Publication No. 61-246161 (1986), for example, by reacting compounds of the formula (XD)

wherein X has the same definition as aforementioned, with the compounds of the formula (III).

wherein Y, A, m and Q have the same definitions as aforementioned.

The reaction can be conducted in an adequate diluent. As the diluent used in that case there can be mentioned, for example, aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroin, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.; acids, for example, acetic acid etc.

The reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from room temperature (20° C.) to about 200° C., preferably from room temperature to 150° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the reaction, the aimed compounds of the formula (IV) can be obtained, for example, by reacting equimolar to a little excess mole amount of the compounds of the formula (II) to 1 mole of the compounds of the formula (XII) in a diluent, for example, acetic acid.

Many of the compounds of the above-mentioned formula (XII) are publicly known, and as their specific examples there can be mentioned, phthalic anhydride, 3-fluorophthalic anhydride, 3-chlorophthalic anhydride, 3-bromophthalic anhydride, 3-iodophthalic anhydride, 3-methanesulfonyloxyphthalic anhydride, etc.

Among the above-mentioned compounds, 3-methanesulfonyloxyphthalic anhydride can be easily obtained from 3-hydroxyphthalic anhydride and methanesulfonyl chloride according to the process described in Tetrahedron Letters Vol. 29, p. 5595-8 (1988).

As specific examples of the compounds of the formula (IV), used as starting materials in the preparation process (b), there can be mentioned the following:

-   4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]phenyl}-isoindole-1,3-dione, -   2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-bromo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-bromo-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-bromo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-difluoromethoxy-3-trifluoromethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-hexafluoro-n-propyl-1H-pyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-methanesulfonyloxy-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[5-difluoromethoxy-1-difluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[5-difluoromethyl-3-trifluoromethyl-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-methanesulfonyloxy-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-(1,2,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-difluoromethoxy-1-difluoromethyl-3-trifluoromethyl-1H-pyrazol-4-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-hydroxy-3,5-bis(trifluoromethyl)-1H-4,5-dihydropyrazol-1-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[2,4-bis(trifluoromethyl)-1H-imidazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1,2-dihydro-(1,3,4)-triazol-2-on-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[3-(2,2,2-trifluoroethyl)-3-trifluoromethyl-4,5-dihydro-(1,2,4)-triazol-5-on-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[2,5-bis(trifluoromethyl)-(1,3,4)-triazol-1-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[4,6-bis(trifluoromethyl)pyrimidin-2-yl-methyl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[4,6-bis(trifluoromethyl)pyrimidin-2-yloxy]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-[3-methyl-5-trifluoromethyl-1H-pyrazol-1-yl]-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(4-bromo-3-trifluoromethyl-1H-pyrazol-1-yl)phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(3-trifluoromethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[5-hydroxy-3-(2,2,2-trifluoroethyl)-5-trifluoromethyl-1H-4,5-dihydropyrazol-1-yl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[1-(2,2,2-trifluoroethyl)-3-trifluoromethyl-pyrazol-5-yl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(1-difluoromethyl-3-trifluoromethyl-pyrazol-5-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4     (1-difluoromethyl-3-difluoromethoxy-pyrazol-3-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-bromo-2-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}-isoindole-1,3-dione, -   4-bromo-2-[2-methyl-4-(5-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-bromo-2-[2-methyl-4-(3-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-bromo-2-[2-methyl-4-(4-pentafluoroethyl-1H-pyrazol-1-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,4-bis(pentafluoroethyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,5-bis(pentafluoroethyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,4-bis(heptafluoropropyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[3,5-bis(heptafluoropropyl)-1H-pyrazol-1-ylmethyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-pentafluoroethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-heptafluoropropyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(4-trifluoromethyl-2H-1,2,3-triazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(4-(pentafluoroethyl)-thiazol-2-yl-methyl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-{2-methyl-4-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl-sulfanyl]-phenyl}-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(5-trifluoromethyl-1,2,4-oxadiazol-3-yl)-phenyl]-isoindole-1,3-dione, -   4-chloro-2-[2-methyl-4-(1-methyl-5-trifluoromethyl-1H-1,2,4-triazol-3-yl)-phenyl]-isoindole-1,3-dione, -   4-iodo-2-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-isoindole-1,3-dione     and so on.

The compounds of the formula (V), used as starting materials in the preparation process (b), are either compounds well known in the field of organic chemistry or can be synthesized according to the process described in DE-A 20 45 905, WO 01/23350.

As their specific examples there can be mentioned ethylamine, diethylamine, n-propylamine, isopropylamine, n-butylamine, sec-butylamine, isobutylamine, t-butylamine, t-amylamine, 2-(methylthio)-ethylamine, 2-(ethylthio)-ethylamine, 1-methyl-2-(methylthio)-ethylamine, 1,1-dimethyl-2-(methylthio)-ethylamine and so on.

The compounds of the formula (VI), used as starting materials in the preparation process (c), include publicly known compounds and can be easily prepared according to the process described in JP-A 11-240857 (1999), JPA 2001-131141, etc.

As their specific examples there can be mentioned the following:

-   N-isopropyl-phthalamic acid, -   3-fluoro-N-isopropyl-phthalamic acid, -   3-chloro-N-isopropyl-phthalamic acid, -   3-bromo-N-isopropyl-phthalamic acid, -   3-iodo-N-isopropyl-phthalamic acid, -   N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   3-chloro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   3-bromo-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   3-iodo-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-fluoro-phthalamic acid, -   3-chloro-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   3-bromo-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid, -   N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-phthalamic acid, -   N-isopropyl-3-methanesulfonyloxy-phthalamic acid, -   N-(1-methyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic     acid, -   N-(1-methyl-2-methylsulfanyl-ethyl)-3-nitro-phthalamic acid, -   3-chloro-N-(2-ethylsulfanyl-1-methyl-ethyl)-phthalamic acid, -   3-bromo-N-(2-ethylsulfanyl-1-methyl-ethyl)-phthalamic acid, -   N-(2-ethylsulfanyl-1-methyl-ethyl)-3-iodo-phthalamic acid, -   N-(2-ethylsulfanyl-1-methyl-ethyl)-3-nitro-phthalamic acid, -   N-(2-ethylsulfanyl-1-methyl-ethyl)-3-methanesulfonyloxy-phthalamic     acid, -   N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic     acid and so on.

The above-mentioned compounds of the formula (VI) can be easily obtained generally by reacting phthalic anhydrides of the aforementioned formula (XII)

wherein X has the same definition as aforementioned, with amines of the formula

H₂N—R¹  (XIII)

wherein R¹ has the same definitions as aforementioned,

The compounds of the above-mentioned formula (XIII) are well known in the field of organic chemistry and there can be specifically mentioned, for example, ethylamine, n-propylamine, isopropylamine, n-butylamine, sec-butylamine, isobutylamine, t-butylamine, t-amylamine, 2-(methylthio)ethylamine, 2-(ethylthio)ethylamine, 1-methyl-2-(methylthio)ethylamine, 1,1-dimethyl-2-(methylthio)ethylamine, etc.

These amines can be easily obtained also by the process described in DE-A 20 45 905, WO 01/23350, etc.

The above-mentioned reaction of the compounds of the formula (XII) with the amines of the formula (XIII) can be conducted according to the process described in, for example, J. Org. Chem., Vol. 46, p. 175 (1981) etc.

Said reaction can be conducted in an adequate diluent, and as examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (TIM, diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.

The above-mentioned reaction can be conducted in the presence of a base, and as said base there can be mentioned, for example, tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO), 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.

The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −70 to about 100° C., preferably from about −50 to about 80° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the above-mentioned reaction, the aimed compounds of the formula (VI) can be obtained, for example, by reacting 1-4 moles of the compounds of the formula (XIII) to 1 mole of the compounds of the formula (XII) in a diluent, for example, acetonitrile.

The compounds of the formula (VII), used as starting materials in the preparation process (d), are novel compounds and can be easily obtained, for example, by reacting the compounds of the formula (VIII), starting materials in the below-mentioned preparation process (e), according to the process described in J. Med. Chem., Vol. 10, p. 982 (1967) etc. in the presence of a condensing agent.

As specific examples of the compounds of the formula (VII), there can be mentioned the following:

-   1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1H-pyrazole, -   1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1H-pyrazole, -   1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(trifluoromethyl)-1,2,4-triazole, -   1-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-3,5-bis(trifluoromethyl)-1,1-pyrazole, -   1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,4-bis(pentafluoroethyl)-1H-pyrazole, -   1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(pentafluoroethyl)-1H-pyrazole, -   1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,4-bis(heptafluoropropyl)-1H-pyrazole, -   1-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methyl-benzyl]-3,5-bis(heptafluoropropyl)-1H-pyrazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,3,4-oxadiazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(pentafluoroethyl)-1,3,4-oxadiazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(heptafluoropropyl)-1,3,4-oxadiazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-5-(trifluoromethyl)-1,3,4-oxadiazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-4-(trifluoromethyl)-2H-1,2,3-triazole, -   2-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylbenzyl]-4-(pentafluoroethyl)-thiazole, -   5-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]sulfanyl-1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazole, -   3-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole, -   3-[4-(4-chloro-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-1-methyl-5-(trifluoromethyl)-1H-1,2,4-triazole, -   2-[4-(4-iodo-3-oxo-3H-isobenzofuran-1-ylideneamino)-3-methylphenyl]-5-(trifluoromethyl)-1,3,4-oxadiazole     and so on.

The compounds of the formula (V), similarly used as starting materials in the preparation process (d), are the same as explained in the aforementioned preparation process (b).

The compounds of the formula (VIII), used as starting materials in the preparation process (e), are novel compounds and can be easily obtained, for example, by reacting phthalic anhydrides of the aforementioned formula (XII) with the compounds of the aforementioned formula (III).

The above-mentioned reaction can be conducted in an adequate diluent, and as examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile; acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.

The above-mentioned reaction can be conducted in the presence of a base, and as said base there can be mentioned tertiary amines, dialkylaminoanilines and pyridines, for example, triethylamine, 1,1,4,4-tetramethylethylenediamine (TMEDA), N,N-dimethylaniline, N,N-diethylaniline, pyridine, 4-dimethylaminopyridine (DMAP), 1,4-diazabicyclo[2,2,2]octane (DABCO) and 1,8-diazabicyclo[5,4,0]undec-7-ene (DBU), etc.

The above-mentioned reaction can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −70 to about 100° C., preferably from about −50 to about 80° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

As specific examples of the compounds of the formula (VIII), there can be mentioned the following:

-   N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-2-methyl-phenyl}-6-iodo-phthalamic     acid, -   N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl-methyl]-2-methyl-phenyl}-6-chloro-phthalamic     acid, -   N-{4-[3,5-bis(trifluoromethyl)-(1,2,4)-triazol-1-yl-methyl]-2-methyl-phenyl}-6-iodo-phthalamic     acid, -   N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-2-methyl-phenyl}-6-iodo-phthalamic     acid, -   N-{4-[3,4-bis(pentafluoroethyl)-1H-pyrazol-1-yl-methyl]phenyl}-6-chloro-phthalamic     acid, -   N-{4-[3,5-bis(pentafluoroethyl)-1H-pyrazol-1-yl-methyl]-phenyl}-6-chloro-phthalamic     acid, -   N-{4-[3,4-bis(heptafluoropropyl)-1H-pyrazol-1-yl-methyl]-phenyl}-6-chloro-phthalamic     acid, -   N-(4-[3,5-bis(heptafluoropropyl)-1H-pyrazol-1-yl-methyl]-phenyl)-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(5-pentafluoroethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(5-heptafluoropropyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl-methyl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(4-trifluoromethyl-2H-1,2,3-triazol-2-yl-methyl)-phenyl]-6-chloro-phthalamic     acid, -   N-{2-methyl-4-(4-pentafluoroethyl-thiazol-2-yl-methyl)-phenyl}-6-chloro-phthalamic     acid, -   N-{2-methyl-4-[1-methyl-3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl-sufanyl]-phenyl}-6-chlorophthalamic     acid, -   N-[2-methyl-4-(5-trifluoromethyl-1,2,4-oxadiazol-3-yl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(1-methyl-5-trifluoromethyl-1H-1,2,4-triazol-3-yl)-phenyl]-6-chloro-phthalamic     acid, -   N-[2-methyl-4-(5-trifluoromethyl-1,3,4-oxadiazol-2-yl)-phenyl]-6-iodo-phthalamic     acid and so on.

The compounds of the formula (V), similarly used as starting materials in the preparation process (e), can be the same as ones used in the aforementioned preparation processes (b) and (d).

The compounds of the formula (If), used as starting materials in the preparation process (f), are compounds included in the formula (I) of the present invention.

By oxidizing the group R^(If) in the compounds of the formula (If), namely, C₁₋₆alkylthio-C₁₋₆alkyl, the compounds of the formula (I), in which the group R^(If) corresponds to C₁₋₆ alkylsulfinyl-C₁₋₆alkyl or C₁₋₆alkylsulfonyl-C₁₋₆alkyl, can be obtained.

The compounds of the formula (If) can be prepared by the processes of the aforementioned preparation processes (a), (b), (c), (d) and/or (e).

As specific examples of the compounds of the formula (If), there can be mentioned the following:

-   3-iodo-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   N²-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-N¹-{2-methyl-4-[3,5-bis(trifluoro-methyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   3-iodo-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,5-bis(trifluoromethyl)-(1,2,4)-triazol-1-ylmethyl]-phenyl}phthalamide, -   3-chloro-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   3-chloro-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,4-bis(pentafluoro-ethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   3-chloro-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,5-bis(pentafluoro-ethyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   3-chloro-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,4-bis(heptafluoro-propyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide, -   3-chloro-N²-(1-methyl-2-methylsulfanyl-ethyl)-N¹-{2-methyl-4-[3,5-bis(heptafluoro-propyl)-1H-pyrazol-1-ylmethyl]-phenyl}phthalamide     and so on

The reaction of the aforementioned preparation process (a) can be conducted in an adequate diluent singly or mixed. As examples of the diluent used in that case there can be mentioned water; aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.

The preparation process (a) can be conducted in the presence of an acid catalyst, and as examples of said acid catalyst there can be mentioned mineral acids, for example, hydrochloric acid and sulfuric acid; organic acids, for example, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, etc.

The preparation process (a) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −20 to about 100° C., preferably from about 0 to about 100° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the preparation process (a), the aimed compounds of the formula (I) can be obtained, for example, by reacting 1 to a little excess mole amount of the compounds of the formula (III) to 1 mole of the compounds of the formula (II) in a diluent, for example, 1,2-dichloroethane in the presence of 0.01-0.1 mole amount of p-toluenesulfonic acid.

The reaction of the aforementioned preparation process (b) can be conducted in an adequate diluent. As examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (Tiff), diethylene glycol dimethyl ether (DGM), etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, hexamethyl phosphoric triamide (HMPA), etc.

The preparation process (b) can be conducted in the presence of an acid catalyst and as examples of said acid catalyst there can be mentioned mineral acids, for example, hydrochloric acid and sulfuric acid; organic acids, for example, acetic acid, trifluoroacetic acid, propionic acid, methanesulfonic acid, p-toluenesulfonic acid, etc.

The preparation process (b) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −20 to about 150° C., preferably from room temperature (20° C.) to about 100° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the preparation process (b), the aimed compounds of the formula (I) can be obtained, for example, by reacting 1-25 moles of the compounds of the formula (V) to 1 mole of the compounds of the formula (IV) in a diluent, for example, dioxane in the presence of 0.01-0.5 mole amount of acetic acid.

The aforementioned preparation processes (c), (d) and (e) can be conducted under the similar condition as the above-mentioned preparation process (a).

The reaction of the aforementioned preparation process (f) can be conducted in an adequate diluent. As examples of the diluent used in that case there can be mentioned aliphatic, alicyclic and aromatic hydrocarbons (may be optionally chlorinated), for example, benzene, toluene, xylene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, dichlorobenzene, etc.; alcohols, for example, methanol, ethanol, isopropanol and butanol; acids; formic acid, acetic acid, etc.

As the oxidizing agents usable in the aforementioned preparation process (f) there can be mentioned, for example, m-chloroperbenzoic acid, peracetic acid, potassium metaperiodate, potassium hydrogen persulfate (oxon), hydrogen peroxide, etc.

The preparation process (f) can be conducted in a substantially wide range of temperature. It is adequate to conduct it at the temperatures in a range of generally from about −50 to about 150° C., preferably from about −10 to about 100° C.

Although said reaction is conducted desirably under normal pressure, it can be operated also under elevated pressure or under reduced pressure.

In conducting the preparation process (f), the aimed compounds of the corresponding formula (I) can be obtained, for example, by reacting 1-5 moles of an oxidizing agent to 1 mole of the compounds of the formula (If) in a diluent, for example, dichloromethane.

The reaction of the aforementioned preparation process (f) can be conducted, for example, according to the process described in JIKKEN KAGAKU KOZA (Lecture on experimental chemistry) edited by the Chemical Society of Japan, 4^(th) ed., Vol. 24, p. 350 (1992) published by MARUZEN or ibid. p. 365.

The compounds of the formula (I) of the present invention show strong insecticidal action. The compounds of the formula (I), according to the present invention can, therefore, be used as insecticidal agents. And the active compounds of the formula (I) of the present invention exhibit exact controlling effect against harmful insects without giving phytotoxicity on cultured plants. And the compounds of the present invention can be used for controlling a wide variety of pests, for example, harmful sucking insects, biting insects and other plant-parasitic pests, stored grain pests, hygienic pests, etc. and applied for their extermination.

As examples of such pests there can be mentioned the following pests:

As insects, there can be mentioned:

Coleoptera pests, for example, Callosobruchus Chinensis, Sitophilus zeamais, Tribolium castaneum, Epilachna vigintioctomaculata, Agriotes fuscicollis, Anomala rufocuprea, Leptinotarsa decemlineata, Diabrotica spp., Monochamus alternatus, Lissorhoptrus oryzophilus, Lyctus bruneus;

Lepidoptera pests, for example,

Lymantria dispar, Malacosoma neustria, Pieris rapae, Spodoptera litura, Mamestra brassicae, Chilo suppressalis, Pyrausta nubilalis, Ephestia cautella, Adoxophyes orana, Carpocapsa pomonella, Agrotis fucosa, Galleria mellonella, Plutella maculipennis, Heliothis virescens, Phyllocnistis citrella;

Hemiptera pests, for example,

Nephotettix cincticeps, Nilaparvata lugens, Pseudococcus comstocki, Unaspis yanonensis, Myzus persicae, Aphis pomi, Aphis gossypii, Rhopalosiphum pseudobrassicas, Stephanitis nashi, Nazara spp., Trialeurodes vaporariorum, Psylla spp.;

Thysanoptera pests, for example,

Thrips palmi, Frankliniella occidental;

Orthoptera pests, for example,

Blatella gennanica, Periplaneta americana, Gryllotalpa africana, Locusta migratoria migratoriodes;

Homoptera pests, for example,

Reticulitermes speratus, Coptotennes formosanus;

Diptera pests, for example,

Musca domestica, Aedes aegypti, Hylemia platura, Culex pipiens, Anopheles slnensis, Culex tritaeniorlzynchus, Liriomyzae trifolii etc.

Moreover, as mites there can be mentioned, for example,

Tetranychus cinnabarinus, Tetranychus urticae, Panonychus citri, Aculops pelekassi, Tarsonemus spp., etc.

Furthermore, as nematodes there can be mentioned, for example,

Meloidogyne incognita, Bursaphelenchus lignicolus Mamiya et Kiyohara, Aphelenchoides besseyi, Heterodera glycines, Pratylenchus spp., etc.

In addition, in the field of veterinary medicine, the novel compounds of the present invention can be effectively used against various harmful animal-parasitic pests (endoparasites and ectoparasites), for example, insects and helminthes. As examples of such animal-parasitic pests there can be mentioned the following pests:

As insects there can be mentioned, for example,

Gastrophilus spp., Stomoxys spp., Trichodectes spp., Rhodnius spp., Ctenocephalides canis, Cimex lectularius etc.

As mites there can be mentioned, for example,

Ornithodoros spp., Ixodes spp., Boophilus spp., etc.

In the present invention, substances having insecticidal action against pests, which include all of them, are in some cases called as insecticides.

All plants and plant parts can be treated in accordance with the invention. Plants are to be understood as meaning in the present context all plants and plant populations such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional plant breeding and optimization methods or by biotechnological and genetic engineering methods or by combinations of these methods, including the transgenic plants and including the plant cultivars protectable or not protectable by plant breeders' rights. Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoot, leaf, flower and root, examples which may be mentioned being leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. The plant parts also include harvested material, and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.

Treatment according to the invention of the plants and plant parts with the active compounds is carried out directly or by allowing the compounds to act on the surroundings, environment or storage space by the customary treatment methods, for example by immersion, spraying, evaporation, fogging, scattering, painting on and, in the case of propagation material, in particular in the case of seeds, also by applying one or more coats.

The active compounds, according to the present invention, can be converted into the customary formulation forms, when they are used as insecticides. As formulation forms there can be mentioned, for example, solutions, emulsions, wettable powders, water dispersible granules, suspensions, powders, foams, pastes, tablets, granules, aerosols, natural and synthetic materials impregnated with active compound, microcapsules, seed coating agents, formulations used with burning equipment (as burning equipment, for example, fumigation and smoking cartridges, cans, coils, etc.), ULV [cold mist, warm mist], etc.

These formulations can be produced according to per se known methods, for example, by mixing the active compounds with extenders, namely liquid diluents or carriers; liquefied gas diluents or carriers; solid diluents or carriers, and optionally with surface-active agents, namely emulsifiers and/or dispersants and/or foam-forming agents.

In case that water is used as extender, for example, organic solvents can also be used as auxiliary solvents.

As liquid diluents or carriers there can be mentioned, for example, aromatic hydrocarbons (for example, xylene, toluene, alkylnaphthalene, etc.), chlorinated aromatic or chlorinated aliphatic hydrocarbons (for example, chlorobenzenes, ethylene chlorides, methylene chloride, etc.), aliphatic hydrocarbons [for example, cyclohexane etc. or paraffins (for example, mineral oil fractions etc.)], alcohols (for example, butanol, glycols and their ethers, esters, etc.), ketones (for example, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, etc.), strongly polar solvents (for example, dimethylformamide, dimethyl sulfoxide, etc.), and water.

Liquefied gas diluents or carriers are substances that are gases at normal temperature and pressure and there can be mentioned, for example, aerosol propellants such as butane, propane, nitrogen gas, carbon dioxide, halogenated hydrocarbons.

As solid diluents there can be mentioned, for example, ground natural minerals (for example, kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite, diatomaceous earth, etc.), ground synthetic minerals (for example, highly dispersed silicic acid, alumina, silicates, etc.).

As solid carriers for granules there can be mentioned, for example, crushed and fractionated rocks (for example, calcite, marble, pumice, sepiolite, dolomite, etc.), synthetic granules of inorganic or organic meals, particles of organic materials (for example, saw dust, coconut shells, maize cobs, tobacco stalks, etc.), etc.

As emulsifiers and/or foam-forming agents, there can be mentioned, for example, nonionic and anionic emulsifiers [for example, polyoxyethylene fatty acid esters, polyoxyethylene fatty acid alcohol ethers (for example, alkylaryl polyglycol ethers), alkylsulfonates, alkylsulfates, arylsulfonates, etc.], albumin hydrolysis products, etc.

Dispersants include, for example, lignin sulfite waste liquor and methyl cellulose.

Tackifiers can also be used in formulations (powders, granules, emulsifiable concentrates). As said tackifiers, there can be mentioned, for example, carboxymethyl cellulose, natural or synthetic polymers (for example, gum Arabic, polyvinyl alcohol, polyvinyl acetate, etc.).

Colorants can also be used. As said colorants there can be mentioned, for example, inorganic pigments (for example, iron oxide, titanium oxide, Prussian Blue, etc,), organic dyestuffs such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs, and further trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.

Said formulations can contain the aforementioned active component of the amount in the range of generally 0.1-95% by weight, preferably 0.5-90% by weight.

The active compounds of the formula (I) of the present invention can exist also as a mixed agent with other active compounds, for example, insecticides, poisonous baits, bactericides, miticides, nematicides, fungicides, growth regulators or herbicides in the form of their commercially useful formulations and in the application forms prepared from such formulations. Here, as the above-mentioned insecticides, there can be mentioned, for example, organophosphorous agents, carbamate agents, carboxylate type chemicals, chlorinated hydrocarbon type chemicals, insecticidal substances produced by microorganisms, etc.

Further, the active compounds of the formula (I) of the present invention can exist also as a mixed agent with a synergist, and such formulations and application forms can be mentioned as commercially useful. Said synergist itself must not be active, but is a compound that enhances the action of the active compound.

Particularly favourable mixing components are, for example, the following compounds:

Fungicides:

2-phenylphenol; 8-hydroxyquinoline sulfate; acibenzolar-S-methyl; aldimorph; amidoflumet; ampropylfos; ampropylfos-potassium; andoprim; anilazine; azaconazole; azoxystrobin; benalaxyl; benalaxyl-M; benodanil; benomyl; benthiavalicarb-isopropyl; benzamacril; benzamacril-isobutyl; bilanafos; binapacryl; biphenyl; bitertanol; blasticidin-S; boscalid; bromuconazole; bupirimate; buthiobate; butylamine; calcium polysulfide; capsimycin; captafol; captan; carbendazim; carboxin; carpropamid; carvone; chinomethionat; chlobenthiazone; chlorfenazole; chloroneb; chlorothalonil; chlozolinate; clozylacon; cyazofamid; cyflufenamid; cymoxanil; cyproconazole; cyprodinil; cyprofuram; Dagger G; debacarb; dichlofluanid; dichlone; dichlorophen; diclocymet; diclomezine; dicloran; diethofencarb; difenoconazole; diflumetorim; dimethirimol; dimethomorph; dimoxystrobin; diniconazole; diniconazole-M; dinocap; diphenylamine; dipyrithione; ditalimfos; dithianon; dodine; drazoxolon; edifenphos; epoxiconazole; ethaboxam; ethirimol; etridiazole; famoxadone; fenamidone; fenapanil; fenarimol; fenbuconazole; fenfuram; fenhexamid; fenitropan; fenoxanil; fenpiclonil; fenpropidin; fenpropimorph; ferbam; fluazinam; flubenzimine; fludioxonil; flumetover, flumorph; fluoromide; fluoxastrobin; fluquinconazole; flurprimidol; flusilazole; flusulfamide; flutolanil; flutriafol; folpet; fosetyl-A1; fosetyl-sodium; fuberidazole; furalaxyl; furametpyr; furcarbanil; furmecyclox; guazatine; hexachlorobenzene; hexaconazole; hymexazol; imazalil; imibenconazole; iminoctadine triacetate; iminoctadine tris(albesilate); iodocarb; ipconazole; iprobenfos; iprodione; iprovalicarb; irumamycin; isoprothiolane; isovaledione; kasugamycin; kresoxim-methyl; mancozeb; maneb; meferimzone; mepanipyrim; mepronil; metalaxyl; metalaxyl-M; metconazole; methasulfocarb; methfuroxam; metiram; metominostrobin; metsulfovax; mildiomycin; myclobutanil; myclozolin; natamycin; nicobifen; nitrothal-isopropyl; noviflumuron; nuarimol; ofurace; orysastrobin; oxadixyl; oxolinic acid; oxpoconazole; oxycarboxin; oxyfenthiin; paclobutrazol; pefurazoate; penconazole; pencycuron; phosdiphen; phthalide; picoxystrobin; piperalin; polyoxins; polyoxorim; probenazole; prochloraz; procymidone; propamocarb; propanosine-sodium; propiconazole; propineb; proquinazid; prothioconazole; pyraclostrobin; pyrazophos; pyrifenox; pyrimethanil; pyroquilon; pyroxyfur; pyrrolnitrin; quinconazole; quinoxyfen; quintozene; simeconazole; spiroxamine; sulfur; tebuconazole; tecloftalam; tecnazene; tetcyclacis; tetraconazole; thiabendazole; thicyofen; thifluzamide; thiophanate-methyl; thiram; tioxymid; tolclofos-methyl; tolylfluanid; triadimefon; triadimenol; triazbutil; triazoxide; tricyclamide; tricyclazole; tridemorph; trifloxystrobin; triflumizole; triforine; triticonazole; uniconazole; validamycin A; vinclozolin; zineb; ziram; zoxamide; (2S)-N-[2-[4-[[3-(4-chlorophenyl)-2-propynyl]oxy]-3-methoxyphenyl]ethyl]-3-methyl-2-[(methylsulfonyl)amino]-butanamide; 1-(1-naphthalenyl)-1H-pyrrol-2,5-dione; 2,3,5,6-tetrachloro-4-(methylsulfonyl)-pyridine; 2-amino-4-methyl-N-phenyl-5-thiazolecarboxamide; 2-chloro-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-3-pyridinecarboxamide; 3,4,5-trichloro-2,6-pyridinedicarbonitrile; actinovate; cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol; methyl 1-(2,3-dihydro-2,2-dimethyl-1H-inden-1-yl)-1H-imidazole-5-carboxylate; mono potassium carbonate; N-(6-methoxy-3-pyridinyl)-cyclopropane carboxamide; N-butyl-8-(1,1-dimethylethyl)-1-oxaspiro[4.5]decan-3-amine; sodium tetrathiocarbonate; and copper salts and preparations, such as Bordeaux mixture; copper hydroxide; copper naphthenate; copper oxychloride; copper sulphate; cufraneb; copper oxide; mancopper; oxine-copper.

Bactericides:

bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.

Insecticides/Acaricides/Nematicides:

1. Acetylcholinesterase (AChE) inhibitors

1.1 Carbamates (e.g. alanycarb, aldicarb, aldoxycarb, allyxycarb, aminocarb, azamethiphos, bendiocarb, benfuracarb, bufencarb, butacarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, chloethocarb, coumaphos, cyanofenphos, cyanophos, dimetilan, ethiofencarb, fenobucarb, fenothiocarb, formetanate, furathiocarb, isoprocarb, metam-sodium, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, promecarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, xylylcarb)

1.2 Organophosphates (e.g. acephate, azamethiphos, azinphos (-methyl, -ethyl), bromophos-ethyl, bromfenvinfos (-methyl), butathiofos, cadusafos, carbophenothion, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos (-methyl/-ethyl), coumaphos, cyanofenphos, cyanophos, chlorfenvinphos, demeton-s-methyl, demeton-s-methylsulphon, dialifos, diazinon, dichlofenthion, dichloriros/ddvp, dicrotophos, dimethoate, dimethylvinphos, dioxabenzofos, disulfoton, epn, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate, heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isopropyl o-salicylate, isoxatbion, malathion, mecarbam, methacrifos, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion (-methyl/-ethyl), phenthoate, phorate, phosalone, phosmet, phosphamidon, phosphocarb, phoxim, pirimiphos (-methyl/-ethyl), profenofos, propaphos, propetamphos, prothiofos, prothoate, pyraclofos, pyridaphenthion, pyridathion, quinalphos, sebufos, sulfotep, sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, triazophos, triclorfon, vamidothion)

2. Sodium channel modulators/voltage dependant sodium channel blockers

2.1 Pyrethroids (e.g. acrinathrin, allethrin (d-cis-trans, d-trans), beta-cyflutbrin, bifenthrin, bioallethrin, bioallethrin-s-cyclopentyl-isomer, bioethanometbrin, biopermethrin, bioresmethrin, chlovaporthrin, cis-cypermethrin, cis-resmethrin, cis-permethrin, clocythrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin (alpha-, beta-, theta-, zeta), cyphenothrin, DDT, deltamethrin, empenthrin (1R-isomer), esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin, fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumetbrin, fluvalinate, fubfenprox, gamma-cyhalothrin, imiprothrin, kadethrin, lambda-cyhalothrin, metofluthrin, permethrin (cis-, trans), phenothrin (1R-trans isomer), prallethrin, proflutbrin, protrifenbute, pyresmethrin, resmethrin, RU 15525, silafluofen, tau-fluvalinate, tefluthrin, terallethrin, tetramethrin (1R-isomer), tralomethrin, transfluthrin, ZXI 8901, pyrethrins (pyrethrum))

2.2 Oxadiazine (e.g. indoxacarb)

3. Acetylcholine receptor agonists/-antagonists

3.1 Chloronicotinyls/neonicotinoids (e.g. acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid, thiamethoxam)

3.2 nicotine, bensultap, cartap

4. Acetylcholine receptor modulators

4.1 Spinosyns (e.g. spinosad)

5. GABA gated chloride channel antagonists

5.1 Cyclodiene organochlorines (e.g. camphechlor, chlordane, endosulfan, gamma HCH, HCH, heptachlor, lindane, methoxychlor

5.2 Fiproles (e.g. acetoprole, ethiprole, fipronil, vaniliprole)

6. Chloride channel activators

6.1 Mectins (e.g. abaraectin, avermectin, emamectin, emamectin-benzoate, ivermectin, milbemectin, milbemycin)

7. Juvenile hormone mimics

(e.g. diofenolan, epofenonane, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxifen, triprene)

8. Ecdysone agonists/disruptors

8.1 Diacylhydrazines (e.g. chromafenozide, halofenozide, methoxyfenozide, tebufenozide)

9. Inhibitors of chitin biosynthesis

9.1 Benzoylureas (e.g. bistrifluoron, chlofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluoron, teflubenzuron, tifiumuron)

9.2 buprofezin

9.3 cyromazine

10. Inhibitors of oxidative phosphorylation, ATP-disruptors

10.1 diafenthiuron

10.2 Organotins (e.g. azocyclotin, cyhexatin, fenbutatin-oxide)

11. Decoupler of oxidative phoshorylation by diruption of H proton gradient

11.1 Pyrroles (e.g. chlorfenapyr)

11.2 Dinitrophenoles (e.g. binapacyrl, dinobuton, dinocap, DNOC)

12. Site I electron transport inhibitors

12.1 METT's (e.g. fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad)

12.2 hydramethyhione

12.3 dicofol

13. Site II electron transport inhibitors

13.1 rotenone

14. Site II electron transport inhibitors

14.1 acequinocyl, fluacrypyrim

15. Microbial disruptors of insect midgut membranes

Bacillus thuringiensis strains

16. Inhibitors of lipid synthesis

16.1 Tetronic acid insecticides (e.g. spirodiclofen, spiromesifen)

16.2 Tetramic acid insecticides [e.g. 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl ethyl carbonate (alias: carbonic acid, 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]-dec-3-en-4-yl ethyl ester, CAS-Reg.-No.: 382608-10-8) and carbonic acid, cis-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl ethyl ester (CAS-Reg.-No.: 203313-25-1)]

17. Carboxamides

(e.g. flonicamid)

18. Octopaminergic agonists

(e.g. amitraz)

19. Inhibitors of magnesium stimulated ATPase

(e.g. propargite)

20. Phthalamides

(e.g. N²-[1,1-dimethyl-2-(methylsulfonyl)ethyl]-3-iodo-N¹-[2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-1,2-benzenedicarboxamide (CAS-Reg.-No.: 272451-65-7, flubendiamide))

21. Nereistoxin analogues

(e.g. thiocyclam hydrogen oxalate, thiosultap-sodium)

22. Biologica, hormones or pheromones

(e.g. azadirachtin, Bacillus spec., Beauveria spec., codlemone, Metarrhizium spec., Paecilomyces spec., thuringiensin, Verticillium spec.)

23. Compounds of unknown or non-specific mode of action

23.1 Fumigants (e.g. aluminium phosphide, methyl bromide, sulfa yl fluoride)

23.2 Selective feeding blockers (e.g. cryolite, flonicamid, pymetrozine)

23.3 Mite growth inhibitors (e.g. clofentezine, etoxazole, hexythiazox)

23.4 amidoflumet, benclothiaz, benzoximate, bifenazate, bromopropylate, buprofezin, chinomethionat, chlordimeform, chlorobenzilate, chloropicrin, clothiazoben, cycloprene, cyflumetofen, dicyclanil, fenoxacrim, fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure, hydramethylnone, japonilure, metoxadiazone, petroleum, piperonyl butoxide, potassium oleate, pyrafluprole, pyridalyl, pyriprole, sulfluramid, tetradifon, tetrasul, triarathene, verbutin

further the compound 3-methyl-phenyl-propylcarbamate (Tsumacide Z), the compound 3-(5-chloro-3-pyridinyl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]octan-3-carbonitrile (CAS-Reg.-Nr. 185982-80-3) and the corresponding 3-endo isomer (CAS-Reg.-Nr. 185984-60-5) (cf. WO 96/37494, WO 98/25923), and preparations comprising insecticidal active plant extracts, nematodes, fungi or viruses.

A mixture with other known active compounds, such as herbicides, fertilizers, growth regulators, safeners and/or semiochemicals is also possible.

When used as insecticides, the active compounds according to the invention can furthermore be present in their commercially available formulations and in the use forms, prepared from these formulations, as a mixture with synergistic agents. Synergistic agents are compounds, which increase the action of the active compounds, without it being necessary for the synergistic agent added to be active itself.

When used as insecticides, the active compounds according to the invention can furthermore be present in their commercially available formulations and in the use forms, prepared from these formulations, as a mixture with inhibitors which reduce degradation of the active compound after use in the vicinity of the plant, on the surface of parts of plants or in plant tissues.

The content of the active compounds of the formula (I) of the present invention in a commercially useful application form can be varied in a wide range.

The concentration of the active compounds of the formula (I) of the present invention at the time of actual usage can be, for example, in the range of 0.0000001-100% by weight, preferably 0.00001-1% by weight.

The compounds of the formula (I) of the present invention can be applied by usual methods suitable to the application forms.

In case of application against hygiene pests and pests of stored products, the active compounds of the present invention have a good stability against alkali on limed substrates and further show an excellent residual effectiveness on wood and soil.

As already mentioned above, it is possible to treat all plants and their parts according to the invention. In a preferred embodiment, wild plant species and plant cultivars, or those obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and parts thereof, are treated. In a further preferred embodiment, transgenic plants and plant cultivars obtained by genetic engineering, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated. The term “parts” or “parts of plants” or “plant parts” has been explained above.

Particularly preferably, plants of the plant cultivars which are in each case commercially available or in use are treated according to the invention. Plant cultivars are to be understood as meaning plants having certain properties (“traits”) which have been obtained by conventional breeding, by mutagenesis or by recombinant DNA techniques. These can be cultivars, bio- or genotypes.

Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also result in superadditive (“synergistic”) effects. Thus, for example, reduced application rates and/or a widening of the activity spectrum and/or an increase in the activity of the substances and compositions to be used according to the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products are possible which exceed the effects which were actually to be expected.

The transgenic plants or plant cultivars (i.e. those obtained by genetic engineering) which are preferably to be treated according to the invention include all plants which, in the genetic modification, received genetic material which imparted particularly advantageous useful traits to these plants. Examples of such traits are better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering performance, easier harvesting, accelerated maturation, higher harvest yields, better quality and/or a higher nutritional value of the harvested products, better storage stability and/or processability of the harvested products. Further and particularly emphasized examples of such traits are a better defence of the plants against animal and microbial pests, such as against insects, mites, phytopathogenic fungi, bacteria and/or viruses, and also increased tolerance of the plants to certain herbicidally active compounds. Examples of transgenic plants which may be mentioned are the important crop plants, such as cereals (wheat, rice), maize, soya beans, potatoes, cotton, tobacco, oilseed rape and also fruit plants (with the fruits apples, pears, citrus fruits and grapes), and particular emphasis is given to maize, soya beans, potatoes, cotton, tobacco and oilseed rape. Traits that are emphasized are in particular increased defence of the plants against insects, arachnids, nematodes and worms by toxins formed in the plants, in particular those formed in the plants by the genetic material from Bacillus thuringiensis (for example by the genes CryIA(a), CryIA(b), CryIA(c), CryIIA, CryIIIA, CryIIIB2, Cry9c, Cry2Ab, Cry3Bb and CryIF and also combinations thereof) (hereinbelow referred to as “Bt plants”). Traits that are also particularly emphasized are the increased defence of the plants against fungi, bacteria and viruses by systemic acquired resistance (SAR), systemin, phytoalexius, elicitors and resistance genes and correspondingly expressed proteins and toxins. Traits that are furthermore particularly emphasized are the increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulphonylureas, glyphosate or phosphinotricin (for example the “PAT” gene). The genes which impart the desired traits in question can also be present in combination with one another in the transgenic plants. Examples of “Bt plants” which may be mentioned are maize varieties, cotton varieties, soya bean varieties and potato varieties which are sold under the trade names YIELD GARD® (for example maize, cotton, soya beans), KnockOut® (for example maize), StarLink® (for example maize), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potato). Examples of herbicide-tolerant plants which may be mentioned are maize varieties, cotton varieties and soya bean varieties which are sold under the trade names Roundup Ready® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link® (tolerance to phosphinotricin, for example oilseed rape), IMI® (tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, for example maize). Herbicide-resistant plants (plants bred in a conventional manner for herbicide tolerance) which may be mentioned include the varieties sold under the name Clearfield® (for example maize). Of course, these statements also apply to plant cultivars having these genetic traits or genetic traits still to be developed, which plants will be developed and/or marketed in the future.

The plants listed can be treated according to the invention in a particularly advantageous manner with the compounds of the general formula I and/or the active compound mixtures according to the invention. The preferred ranges stated above for the active compounds or mixtures also apply to the treatment of these plants. Particular emphasis is given to the treatment of plants with the compounds or mixtures specifically mentioned in the present text.

Then the present invention will be described more specifically by examples. The present invention, however, should not be restricted only to them in any way.

SYNTHESIS EXAMPLES Synthesis Example 1

3-(1,1-Dimethyl-2-methylsulfanyl-ethylimino)-4-iodo-3H-isobenzofuran-1-one (0.53 g) and 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (0.45 g) were dissolved in acetonitrile (15 ml), to which p-toluenesulfonic acid monohydrate (0.01 g) was added and the mixture was stirred at 60° C. for 3 hours. After finishing the reaction, the solvent was distilled off under reduced pressure and the residue was purified by silica gel column chromatography to obtaining N¹-[4-(3,5-bistrifluoromethylpyrazol-1-ylmethyl)-2-methylphenyl]-N²-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.91 g). mp. 83-87° C.

Synthesis Example 2

N¹-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N²-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.5 g) was dissolved in dichloromethane, to which m-chloroperbenzoic acid (0.26 g) was added and the mixture was stirred for 5 hours under ice cooling. After finishing the reaction, the mixture was washed successively with aqueous solution of sodium thiosulfate, saturated aqueous solution of sodium bicarbonate and saturated aqueous solution of sodium chloride, and dried with anhydrous magnesium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain N¹-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N²-(2-methanesulfinyl-1,1-dimethylethyl)-3-iodophthalamide (0.30 g).

¹H-NMR (CDCl₃, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s), 6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m).

Synthesis Example 3

N¹-{4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-N²-(1,1-dimethyl-2-methylsulfanylethyl)-3-iodophthalamide (0.30 g) was dissolved in dichloromethane, to which m-chloroperbenzoic acid (0.26 g) was added and the mixture was stirred at room temperature for 5 hours. After finishing the reaction, the mixture was washed successively with aqueous solution of sodium thiosulfate, saturated aqueous solution of sodium bicarbonate and saturated aqueous solution of sodium chloride, and dried with anhydrous magnesium sulfate. After distilling off the solvent, the obtained crude crystals were washed with petroleum ether to obtain N¹-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-3-iodo-N²-(2-methanesulfonyl-1,1-dimethylethyl)phthalamide (0.25 g). mp. 104-107° C.

Synthesis Example 4

A dioxane solution (15 ml) of 2-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindole-1,3-dione (0.94 g), (S)-1-methyl-2-methylsulfanylethylamine (0.63 g) and acetic acid (0.12 g) was refluxed for 18 hours. After cooling to room temperature, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain N¹-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-3-fluoro-N²-[1-(S)-1-methyl-2-methylsulfanyl-ethyl]-phthalamide (0.19 g) (compound No. 549). mp. 66-68° C.

Synthesis Example 5

3-Iodo-N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-phthalamic acid (0.39 g) and N-(3-dimethylaminopropyl)-N¹-ethylcarbonyl diimidazole hydrochloride (0.19 g) were stirred in dichloromethane (10 ml) at room temperature for 30 minutes. Then, 2-methyl-4-[1-(3-trifluoromethyl-1H-pyrazol-1-yl)-ethyl]-aniline (0.30 g) and p-toluenesulphonic acid monohydrate (0.02 g) were added thereto and the mixture was stirred at room temperature for 3 hours. After distilling off the solvent under reduced pressure, the obtained residue was purified by silica gel column chromatography to obtain N²-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-iodo-N¹-{2-methyl-4-[1-(3-trifluoromethyl-1H-pyrazol-1-yl)-ethyl]-phenyl}-phthalamide (0.38 g) (compound No. 558). mp. 79-86° C.

The compounds of the formula (I), according to the present invention, which can be obtained in the Same manner as the above-mentioned Synthesis Examples 1 to 5 are shown in Table 1, together with the compounds obtained in the above-mentioned Synthesis Examples 1 to 5.

NMR data of the compounds, whose mp. column is marked as ***, are collectively shown in Table 2, separately from Table 1.

TABLE 1

No. R¹ X Y A m Q R² R³ R⁴ mp 1 C(CH₃)₂CH₂SCH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 2 C(CH₃)₂CH₂SOCH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 3 C(CH₃)₂CH₂SO₂CH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 4 CH(CH₃)CH₂SCH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 5 CH(CH₃)CH₂SOCH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 6 CH(CH₃)CH₂SO₂CH₃ 3-H 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 7 CH(CH₃)₂ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 8 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 9 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 80-84 10 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 183-186 11 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 12 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 76-81 (S)-isomer 13 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 185-193 14 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 192-194 (S)-isomer 15 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 16 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 88-93 (S)-isomer 17 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 18 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 19 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 20 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 21 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 22 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 23 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 24 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 25 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 26 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 27 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 28 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 29 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 30 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 31 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 32 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 33 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 34 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 35 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 36 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 37 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 38 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 39 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 40 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 41 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 42 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 43 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 44 CH(CH₃)₂ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 45 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 154-160 46 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 47 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 48 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 147-155 49 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 80-86 (S)-isomer 50 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 51 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 207-209 (S)-isomer 52 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 53 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 77-85 (S)-isomer 54 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 55 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 56 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 57 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 58 C(CH₃)₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 59 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 60 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 61 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 62 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 63 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 64 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 65 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 66 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 67 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 68 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 69 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 70 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 71 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 72 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 73 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 74 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 75 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 76 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 77 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 78 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 79 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 80 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 81 CH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 82 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 83-87 83 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 84 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 104-107 85 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 86 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 85-93 (S)-isomer 87 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 213-215 88 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 193-195 (S)-isomer 89 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 90 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 87-93 (S)-isomer 91 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 79-83 (S)-isomer 92 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 93 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 79-91 (S)-isomer 94 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H *** 95 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H 96 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H *** 97 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H *** 98 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H 99 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₃F₇-n H *** 100 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 101 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 102 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 103 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H *** 104 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 105 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H 106 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 107 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H *** 108 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 109 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 110 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 111 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ OCHF₂ H (S)-isomer 112 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 113 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 114 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 115 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 116 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ *** (S)-isomer 117 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 118 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 119 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ 120 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 121 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 122 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 123 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 H H C₂F₅ (S)-isomer 124 C(CH₃)₂CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 125 C(CH₃)₂CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 126 C(CH₃)₂CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 127 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 128 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 177-180 (S)-isomer 129 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 130 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 131 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 132 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 85-93 (S)-isomer 133 CH(CH₃)CH₂SC₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 134 CH(CH₃)CH₂SOC₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 135 CH(CH₃)CH₂SO₂C₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 136 CH(CH₃)₂ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 137 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 70-72 138 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 84-90 139 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 88-95 140 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 76-80 141 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 72-81 (S)-isomer 142 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 186-188 143 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 195-198 (S)-isomer 144 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 116-118 145 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 95-99 (S)-isomer 146 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 73-76 (S)-isomer 147 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 180-183 (S)-isomer 148 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 66-72 (S)-isomer 149 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — *** 150 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 59-64 151 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 82-87 152 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 153 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — *** (S)-isomer 154 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 155 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 175-178 (S)-isomer 156 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 157 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 82-90 (S)-isomer 158 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 159 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 160 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 161 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 162 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 163 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 164 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 165 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 166 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 167 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 168 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 169 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 170 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 171 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 172 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 173 CH(CH₃)₂ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 174 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 77-82 175 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 176 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 151-155 177 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 167-169 178 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 68-73 (S)-isomer 179 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 180 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — *** (S)-isomer 181 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 90-98 182 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ —  99-112 (S)-isomer 183 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 184 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 185 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 186 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 187 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 188 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 189 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 190 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 191 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 192 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 193 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 194 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 195 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 196 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 197 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 198 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 199 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 200 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 201 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 202 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 203 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 204 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 205 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 206 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 207 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 208 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 209 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 210 CH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 102-105 211 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 93-97 212 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 92-93 213 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 104-107 214 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 92-95 215 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 81-90 (S)-isomer 216 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 192-195 217 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 192-199 (S)-isomer 218 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ —  99-104 219 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 164-167 (S)-isomer 220 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 90-94 (S)-isomer 221 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 201-205 (S)-isomer 222 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 91-99 (S)-isomer 223 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 224 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 225 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 226 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 89-94 227 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ —  91-104 (S)-isomer 228 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 229 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 190-193 (S)-isomer 230 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ —  99-116 231 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — 126-132 (S)-isomer 232 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 233 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 234 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 235 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 236 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 237 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ 238 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 85-88 239 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 160-161 (S)-isomer 240 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 241 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 242 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — *** 243 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — 174-178 (S)-isomer 244 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 245 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 246 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 CF₃ CHF₂ — (S)-isomer 247 C(CH₃)₂CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 248 C(CH₃)₂CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 249 C(CH₃)₂CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 250 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 251 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — *** (S)-isomer 252 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 253 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 254 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 255 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 207-208 (S)-isomer 256 CH(CH₃)CH₂SC₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 257 CH(CH₃)CH₂SOC₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 258 CH(CH₃)CH₂SO₂C₂H₅ 3-OSO2CH3 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 259 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 260 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 261 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 262 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 82-90 263 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 264 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q3 OCHF₂ CHF₂ CF₃ 88-99 265 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 266 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 267 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 268 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 149-151 269 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 270 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q4 OCHF₂ CHF₂ CF₃ 81-90 271 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH *** 272 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH 273 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH 274 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH 275 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH 276 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q5 CF₃ CF₃ OH 277 CH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q6 Cl Cl H *** 278 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 279 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 280 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 281 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 149-158 (S)-isomer 282 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 283 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q6 H CF₃ CF₃ 284 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 285 C(CH₃)₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 286 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 287 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 288 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 289 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₂CF₃ CF₃ — 290 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 291 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 292 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 293 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 294 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 295 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q8 CH₂CF₃ CF₃ — 296 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 297 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 298 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 299 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 65-79 (S)-isomer 300 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 301 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 302 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 303 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 304 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 305 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 306 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 307 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q10 CF₃ CF₃ H 308 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 179-181 309 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 310 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 148-153 311 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 312 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 313 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ O 1 Q10 CF₃ CF₃ H 314 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 315 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 316 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 317 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 318 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 209-210 (S)-isomer 319 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 320 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 321 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 322 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H 218-219 (S)-isomer 323 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 324 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 325 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 326 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 327 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 328 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 329 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 330 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 331 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 332 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 333 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H 334 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 335 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 336 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 337 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 338 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 339 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 340 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 341 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 342 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 343 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 344 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 345 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H 346 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 347 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 348 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 349 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 350 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 351 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 352 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 353 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 354 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 355 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 356 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 357 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ 358 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 359 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 360 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 361 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 362 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 363 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 364 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 365 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 366 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 367 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 368 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 369 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H 370 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 371 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 372 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 373 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 374 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 375 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 376 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 377 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 378 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 379 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 380 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 381 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H 382 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 383 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 384 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 385 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 386 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 387 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 388 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 389 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 390 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 391 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 392 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 393 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H 394 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 395 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 396 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 397 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 398 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 399 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 400 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 401 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 402 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 403 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 404 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 405 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ 406 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 407 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 408 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 409 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 410 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 411 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 412 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 413 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 201 414 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 192-206 (S)-isomer 415 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H 416 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 417 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H *** 418 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 419 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 420 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 421 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 422 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H *** 423 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H 424 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H 425 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H 426 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 427 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H 428 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 428 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H 430 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 431 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 432 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 433 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ — 0 Q1 H C₂F₅ H (S)-isomer 434 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H *** 435 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H 436 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H 437 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H 438 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 439 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H 440 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 441 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H 442 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 443 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 444 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 445 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ — 0 Q1 C₂F₅ H H (S)-isomer 446 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 155-157 447 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 448 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 162-168 449 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 450 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 451 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 452 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 453 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ 454 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 455 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 456 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 457 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ — 0 Q1 H H C₂F₅ (S)-isomer 458 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 459 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 460 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 461 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 178-180 462 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 463 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CH₃ CF₃ H 101-112 464 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 465 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 466 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 467 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 187-192 468 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 469 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ CH₃ H 108-116 470 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 471 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 472 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 473 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 109-111 474 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 475 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 C₂F₅ CF₃ H 103-115 476 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 477 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 478 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 479 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 235-237 480 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 481 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H Br 201-209 482 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 483 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 484 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 485 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 173-174 486 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 487 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q1 CF₃ H H 107-109 488 C(CH₃)₂CH₂SCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 489 C(CH₃)₂CH₂SOCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 490 C(CH₃)₂CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 491 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 492 CH(CH₃)CH₂SCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 175-177 (S)-isomer 493 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 494 CH(CH₃)CH₂SOCH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 495 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H 496 CH(CH₃)CH₂SO₂CH₃ 3-OSO2CH3 2-CH₃ — 0 Q1 CF₃ CF₃ H (S)-isomer 497 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 498 C(CH₃)₂CH₃SOCH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 499 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 500 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 101-106 501 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 502 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q5 C₂F₅ CF₃ OH 503 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 504 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 505 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 506 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 106-118 507 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 508 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q11 CH₂CF₃ H CF₃ 127-139 509 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 510 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 511 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 512 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 138-144 513 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 514 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q11 CHF₂ H CF₃ 515 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 516 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 517 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 518 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 83-89 519 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 520 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ — 0 Q12 CHF₂ H OCHF₂ 91-97 521 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ H *** 522 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ H *** 523 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ H *** 524 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ H 525 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H H 526 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H H 527 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H H 528 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H H 529 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H H *** 530 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H H *** 531 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H 532 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H *** (S)-isomer 533 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H 534 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H *** 535 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H (S)-isomer 536 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H *** 537 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H *** 538 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H H *** 539 CH(CH₃)CH₂SCH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 81-83 (S)-isomer 540 CH(CH₃)CH₂SOCH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 541 CH(CH₃)CH₂SO₂CH(CH₃)₂ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 542 CH(CH₃)CH₂SCH(CH₃)₂ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 543 CH(CH₃)CH₂SCH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 161-171 (S)-isomer 544 CH(CH₃)CH₂SOCH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 227-229 (S)-isomer 545 CH(CH₃)CH₂SO₂CH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 215-216 (S)-isomer 546 CH(CH₃)CH₂SCH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 175-179 (S)-isomer 547 CH(CH₃)CH₂SOCH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 225-228 (S)-isomer 548 CH(CH₃)CH₂SO₂CH₃ 3-NO₂ 2-CH₃ CH₂ 1 Q2 CF₃ CF₃ — 206-208 (S)-isomer 549 CH(CH₃)CH₂SCH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 66-68 (S)-isomer 550 CH(CH₃)₂ 3-SCH₃ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** 551 CH(CH₃)CH₂SCH₃ 3-SCH₃ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 552 CH(CH₃)CH₂SCH₃ 3-SO₂CH₃ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** (S)-isomer 553 CH(CH₃)CH₂SCH₃ 3-SCH₂CH₃ 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H *** (S)-isomer 554 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ I *** (S)-isomer 555 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ H H 556 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ H H 78-89 (S)-isomer 557 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ H H 150-152 (S)-isomer 558 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ H H 79-86 559 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 80-91 (S)-isomer 560 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H (S)-isomer 561 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 103-105 (S)-isomer 562 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 84-89 (S)-isomer 563 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 177-179 (S)-isomer 564 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 101-105 (S)-isomer 565 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H  98-106 566 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 132-136 567 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₃ CF₃ H 173-174 568 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ — 87-92 (S)-isomer 569 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ — *** (S)-isomer 570 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ — 91-95 (S)-isomer 571 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ —  98-105 (S)-isomer 572 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ —  98-105 (S)-isomer 573 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH(CH₃) 1 Q2 CF₃ CF₃ — 103-106 (S)-isomer 574 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ C₂F₅ — *** (S)-isomer 575 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ C₂F₅ — (S)-isomer 576 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 CF₃ C₂F₅ — (S)-isomer 577 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q2 CF₃ C₂F₅ — (S)-isomer 578 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 C₂F₅ CF₃ — 83-85 (S)-isomer 579 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 C₂F₅ CF₃ — 121-124 (S)-isomer 580 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 C₂F₅ CF₃ — 87-94 (S)-isomer 581 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 582 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 583 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ S 1 Q10 CF₃ CF₃ H (S)-isomer 584 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ S 1 Q10 CF₃ CF₃ H (S)-isomer 585 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ S 1 Q10 C₂F₅ C₂F₅ H (S)-isomer 586 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ S 1 Q10 C₂F₅ C₂F₅ H (S)-isomer 587 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ S 1 Q13 CF₃ CF₃ — (S)-isomer 588 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ S 1 Q13 CF₃ CF₃ — 223-225 (S)-isomer 589 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ SO₂ 1 Q13 CF₃ CF₃ — (S)-isomer 590 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q7 CH₃ CHF₂ — 591 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q7 CH₃ CHF₂ — 592 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₃ CHF₂ —  99-101 593 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q7 CH₃ CHF₂ — 83-94 594 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q14 H COCF₃ H *** (S)-isomer 595 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q14 I COCF₃ H *** (S)-isomer 596 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q14 C₂F₅ COCF₃ H *** (S)-isomer 597 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₃F₇-n 598 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₄F₉-n 599 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₆F₁₃-n 600 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q1 H H C₈F₁₇-n 601 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₃F₇-n (S)-isomer 602 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 69-72 (S)-isomer 603 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₆F₁₃-n (S)-isomer 604 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₈F₁₇-n (S)-isomer 605 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CH₃ H C₃F₇-n 606 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CH₃ H C₄F₉-n 607 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CH₃ H C₆F₁₃-n 608 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 74-78 (S)-isomer 609 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 176-177 (S)-isomer 610 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 81-87 (S)-isomer 611 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 612 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 613 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 614 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 615 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 616 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 617 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 618 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 619 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n CF₃ H (S)-isomer 620 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 621 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 622 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 623 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 624 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 625 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H 626 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H *** (S)-isomer 627 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H (S)-isomer 628 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H (S)-isomer 629 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H (S)-isomer 630 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H (S)-isomer 631 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ H (S)-isomer 632 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H Cl *** (S)-isomer 633 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H Cl *** (S)-isomer 634 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H Cl *** (S)-isomer 635 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H Br *** (S)-isomer 636 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H I *** (S)-isomer 637 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 73-78 (S)-isomer 638 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 81-84 (S)-isomer 639 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 87-90 (S)-isomer 640 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ *** (S)-isomer 641 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 164-166 (S)-isomer 642 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 75-85 (S)-isomer 643 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₃F₇-n 73-75 (S)-isomer 644 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₃F₇-n 86-88 (S)-isomer 645 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 79-82 (S)-isomer 646 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 73-76 (S)-isomer 647 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 83-88 (S)-isomer 648 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 88-92 (S)-isomer 649 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 84-90 (S)-isomer 650 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 75-78 (S)-isomer 651 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ *** (S)-isomer 652 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 124-125 (S)-isomer 653 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 88-91 (S)-isomer 654 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ *** (S)-isomer 655 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 87-92 (S)-isomer 656 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 100-107 (S)-isomer 657 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 64-65 (S)-isomer 658 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n *** (S)-isomer 659 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 78-81 (S)-isomer 660 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n *** (S)-isomer 661 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 83-85 (S)-isomer 662 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 92-96 (S)-isomer 663 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 72-74 (S)-isomer 664 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 84-88 (S)-isomer 665 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 78-85 (S)-isomer 666 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 78-85 (S)-isomer 667 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 70-74 (S)-isomer 668 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 73-77 (S)-isomer 669 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 77-82 (S)-isomer 670 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 86-90 (S)-isomer 671 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 81-84 (S)-isomer 672 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 147-148 (S)-isomer 673 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H C₂F₅ CF₃ (S)-isomer 674 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ CF₃ (S)-isomer 675 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H C₂F₅ C₂F₅ *** (S)-isomer 676 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H C₂F₅ C₂F₅ (S)-isomer 677 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 678 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 679 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 680 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 681 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — *** (S)-isomer 682 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 683 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 162-164 (S)-isomer 684 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 685 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 103-106 (S)-isomer 686 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 687 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 688 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 689 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 690 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 691 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 692 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 693 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 694 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 695 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 696 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 697 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 698 CH(CH₃)CH₂SC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 699 CH(CH₃)CH₂SOC₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 700 CH(CH₃)CH₂SO₂C₂H₅ 3-Br 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 701 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 702 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 703 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 704 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 705 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 706 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 707 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 708 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — 709 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 710 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 711 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 712 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 713 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₃F₇-n CF₃ — 714 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₃F₇-n CF₃ — *** (S)-isomer 715 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₃F₇-n CF₃ — (S)-isomer 716 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₃F₇-n C₂F₅ — (S)-isomer 717 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₃F₇-n C₂F₅ — (S)-isomer 718 C(CH₃)₂CH₂SCH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 719 C(CH₃)₂CH₂SOCH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 720 C(CH₃)₂CH₂SO₂CH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 721 CH(CH₃)CH₂SOCH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 722 CH(CH₃)CH₂SO₂CH₃ 3-F 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 723 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 63-69 (S)-isomer 724 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 95-97 (S)-isomer 725 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H CF₃ C₃F₇-n 76-81 (S)-isomer 726 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H CF₃ C₃F₇-n *** (S)-isomer 727 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H CF₃ C₃F₇-n *** (S)-isomer 728 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H C₂F₅ C₂F₅ 68-72 (S)-isomer 729 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 H C₂F₅ C₂F₅ *** (S)-isomer 730 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CHF₂ CHF₂ H *** (S)-isomer 731 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H CF₃ 732 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H CF₃ (S)-isomer 733 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H CF₂CHF₂ 734 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H CF₂CHF₂ (S)-isomer 735 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 736 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 737 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₆F₁₃-n 78-82 (S)-isomer 738 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ H C₈F₁₇-n 79-82 (S)-isomer 739 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ CF₃ (S)-isomer 740 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ 741 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ *** (S)-isomer 742 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ 64-67 (S)-isomer 743 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ 83-89 (S)-isomer 744 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₃ 745 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₃ 75-80 (S)-isomer 746 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 747 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 748 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 749 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 750 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 751 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 752 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 753 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 754 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 755 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H C₂F₅  95-100 (S)-isomer 756 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 757 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H C₂F₅ 89-94 (S)-isomer 758 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 759 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ — 0 Q1 C₂F₅ H C₂F₅ 195-195 (S)-isomer 760 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 761 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 70-74 (S)-isomer 762 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 79-84 (S)-isomer 763 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 185-188 (S)-isomer 764 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 C₂F₅ H C₃F₇-n 765 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 766 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 767 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 768 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 769 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 770 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉ 771 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 81-85 (S)-isomer 772 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n (S)-isomer 773 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ 774 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ 775 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ 142-146 (S)-isomer 776 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ (S)-isomer 777 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ (S)-isomer 778 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ CH₃ C₂F₅ *** (S)-isomer 779 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₂F₅ C₂F₅ C₂F₅ (S)-isomer 780 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 781 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 782 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 783 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 784 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 81-83 (S)-isomer 785 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 85-90 (S)-isomer 786 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH(CH₃) 1 Q1 C₃F-n H C₃F₇-n 787 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 788 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 789 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 790 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 791 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 792 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F-n H C₃F₇-n 793 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n C₃F₇-n H 74-78 (S)-isomer 794 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n C₃F₇-n H 72-76 (S)-isomer 795 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 C₃F₇-n C₃F₇-n H 149-150 (S)-isomer 796 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CHFCF₃ CF₃ — 66-69 (S)-isomer 797 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CHFCF₃ CF₃ — 80-85 (S)-isomer 798 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CHFCF₃ CF₃ — 81-86 (S)-isomer 799 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₂CHF₂ CF₂CHF₂ — *** (S)-isomer 800 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₂CHF₂ CF₂CHF₂ — 159-163 (S)-isomer 801 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 CF₂CHF₂ CF₂CHF₂ — 77-83 (S)-isomer 802 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₃F₇-n C₃F₇-n — 803 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 C₄F₉-n H — 218-210 (S)-isomer 804 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q2 SC₃F₇-n CF₃ — 73-76 (S)-isomer 805 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 806 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 807 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 808 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 809 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 810 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 811 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 812 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 813 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 814 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 815 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 816 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 817 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 818 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 819 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 820 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 821 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 822 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 823 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 824 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 825 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 826 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 827 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 828 CH(CH₃)CH₂SC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 829 CH(CH₃)CH₂SOC₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 830 CH(CH₃)CH₂SO₂C₂H₅ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 831 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — 832 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — 833 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — (S)-isomer 834 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₃F₇-n CF₃ — 835 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q9 C₃F₇-n CF₃ — (S)-isomer 836 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ S 1 Q18 CF₃ CH₃ — (S)-isomer 837 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q19 CF₃ CH₃ — (S)-isomer 838 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q17 CF₃ H — 839 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q15 H C₂F₅ — 840 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q15 H C₂F₅ — 71-75 (S)-isomer 841 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q20 CF₃ — — (S)-isomer 842 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q16 C₂F₅ — — 843 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ — 0 Q16 C₃F₇-n — — 844 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 845 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 846 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 847 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ 848 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 849 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 850 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 851 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 852 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 853 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 854 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 855 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 856 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 857 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 858 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 859 CH(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 860 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 861 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 862 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 863 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 864 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 865 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 866 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 867 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 868 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 869 C(CH₃)₂CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 870 C(CH₃)₂CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 871 C(CH₃)₂CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 872 CH(CH₃)CH₂SCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 873 CH(CH₃)CH₂SOCH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 874 CH(CH₃)CH₂SO₂CH₃ 3-Br 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 875 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 80-85 (S)-isomer 876 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 160-162 (S)-isomer 877 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 H H C₄F₉-n 85-89 (S)-isomer 878 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CHF₂ CHF₂ H *** (S)-isomer 879 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H CF₃ 880 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H CF₂CHF₂ 881 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H CF₂CHF₂ (S)-isomer 882 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 883 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₂F₅ 884 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 885 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ H C₄F₉-n 886 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ CF₃ 887 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ CF₃ 888 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 CF₂CHF₂ H C₂F₅ 889 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ 890 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ (S)-isomer 891 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ (S)-isomer 892 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₂CHF₂ H C₂F₅ (S)-isomer 893 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₃ 894 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 895 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 896 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H CF₂CHF₂ (S)-isomer 897 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q1 C₂F₅ H C₂F₅ 898 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 899 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 900 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 901 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 902 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 903 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ 904 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 905 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 906 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 907 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 908 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 909 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 910 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₃F₇-n 911 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 912 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 913 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 90-96 (S)-isomer 914 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ H C₄F₉-n 92-97 (S)-isomer 915 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ F CF₃ 916 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 917 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 918 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 919 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 920 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 89-96 (S)-isomer 921 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₂F₅ 92-96 (S)-isomer 922 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 923 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 924 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 925 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 926 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 927 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₃F₇-n H C₃F₇-n 928 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q2 C₃F₇-n C₃F₇-n — 929 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 930 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 931 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q6 CF₃ CF₃ CF₃ (S)-isomer 932 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q9 CF₃ CF₃ — 933 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 934 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 935 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — 936 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 937 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 938 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 939 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 940 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 941 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q9 C₂F₅ CF₃ — 942 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 943 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 944 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 945 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 946 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 947 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — 948 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 949 CH(CH₃)CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 950 CH(CH₃)CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 951 CH(CH₃)CH₂SC₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 952 CH(CH₃)CH₂SOC₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 953 CH(CH₃)CH₂SO₂C₂H₅ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 954 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH(CH₃) 1 Q9 C₂F₅ C₂F₅ — 955 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — 956 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — 957 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₂F₅ C₂F₅ — (S)-isomer 958 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₃F₇-n CF₃ — 959 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q9 C₃F₇-n CF₃ — (S)-isomer 960 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ S 1 Q18 CF₃ CH₃ — 961 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q19 CF₃ CH₃ — 962 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q17 CF₃ H — 963 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q15 H C₂F₅ — 964 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ — 0 Q20 CF₃ — — 965 CH(CH₃)CH₂SCH₃ 3-I 2-CH₃ — 0 Q16 CF₃ — — 966 C(CH₃)₂CH₂SCH₃ 3-Cl 2-F CH₂ 1 Q1 CF₃ CF₃ H 967 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-F CH₂ 1 Q1 CF₃ CF₃ H 968 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-F CH₂ 1 Q1 CF₃ CF₃ H 969 C(CH₃)₂CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 970 C(CH₃)₂CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 971 C(CH₃)₂CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 972 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 973 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 974 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 975 CH(CH₃)CH₂SCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 976 CH(CH₃)CH₂SOCH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 977 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H (S)-isomer 978 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 979 CH(CH₃)CH₂SOCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 980 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ CF₃ H (S)-isomer 981 C(CH₃)₂CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 CF₃ H C₂F₅ 982 C(CH₃)₂CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 CF₃ H C₃F₇-n 983 C(CH₃)₂CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 CF₃ H C₄F₉-n 984 C(CH₃)₂CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 CF₃ H C₆F₁₃-n 985 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 986 CH(CH₃)CH₂SOCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 987 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 988 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₃F₇-n (S)-isomer 989 CH(CH₃)CH₂SOCH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₃F₇-n (S)-isomer 990 CH(CH₃)CH₂SO₂CH₃ 3-Cl 2-Cl CH₂ 1 Q1 C₂F₅ H C₃F₇-n (S)-isomer 991 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 992 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 993 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q9 CF₃ CF₃ — (S)-isomer 994 CH(CH₃)CH₂SCH₃ 3-Cl 2-Cl CH₂ 1 Q9 C₂F₅ CF₃ — (S)-isomer 995 C(CH₃)₂CH₂SCH₃ 3-I 2-F CH₂ 1 Q1 CF₃ CF₃ H *** 996 C(CH₃)₂CH₂SOCH₃ 3-I 2-F CH₂ 1 Q1 CF₃ CF₃ H 997 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-F CH₂ 1 Q1 CF₃ CF₃ H 113-115 998 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 157-159 999 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 1000 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 CF₃ CF₃ H 129-134 1001 C(CH₃)₂CH₂SCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 1002 C(CH₃)₂CH₂SOCH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 1003 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-CH₃ CH₂ 1 Q1 C₂F₅ CF₃ H 1004 C(CH₃)₂CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ C₂F₅ H 1005 C(CH₃)₂CH₂SOCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ C₂F₅ H 1006 C(CH₃)₂CH₂SO₂CH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ C₂F₅ H 1007 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ H C₂F₅ (S)-isomer 1008 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ H C₃F₇-n (S)-isomer 1009 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ H C₄F₉-n (S)-isomer 1010 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q1 C₂F₅ H C₆F₁₃-n (S)-isomer 1011 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q2 CF₃ CF₃ — (S)-isomer 1012 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q2 C₂F₅ CF₃ — (S)-isomer 1013 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q2 C₂F₅ C₂F₅ — (S)-isomer 1014 CH(CH₃)CH₂SCH₃ 3-I 2-Cl CH₂ 1 Q2 C₃F₇-n CF₃ — (S)-isomer

indicates data missing or illegible when filed

TABLE 2 No. 1 1H-NMR (CDCl3, ppm): 1.4 (6H, s), 2.0 (3H, s), 2.3 (3H, s), 2.9 (2H, s), 5.4 (2H, s), 6.2 (1H, s), 6.9 (1H, s), 7.3-8.7 (8H, m) 3 1H-NMR (CDCl3, ppm): 1.5 (6H, s), 2.2 (3H, s), 2.6 (3H, s), 3.7 (2H, s), 5.4 (2H, s), 6.4 (1H, s), 6.9 (1H, s), 7.3-8.2 (8H, m) 8 1H-NMR (CDCl3, ppm): 1.4 (6H, s), 2.0 (3H, s), 2.3 (3H, s), 2.9 (2H, s), 5.4 (2H, s), 6.1 (1H, s), 6.9 (1H, s), 7.3-8.4 (7H, m) 11 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.9 (3H, s), 2.3 (3H, s), 2.7 (2H, dd), 4.2 (1H, m), 5.4 (2H, s), 6.4 (1H, d), 6.9 (1H, s), 7.3-8.4 (7H, m) 15 1H-NMR (CDCl3, ppm): 1.3 (3H, d), 2.2 (3H, s), 2.8 (3H, s), 3.2 (2H, m), 4.6 (1H, m), 5.4 (2H, s), 6.4 (1H, d), 6.9-8.4 (8H, m) 47 1H-NMR (CDCl3, ppm): 1.6 (6H, s), 2.3 (3H, s), 2.5 (3H, s), 3.5 (2H, s), 5.4 (2H, s), 6.6 (1H, s), 6.9 (1H, s), 7.3-8.2 (7H, m) 52 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.7 (3H, s), 3.2 (2H, m), 4.4 (1H, m), 5.4 (2H, s), 6.9-8.2 (9H, m) 81 1H-NMR (CDCl3, ppm): 1.1 (6H, d), 2.2 (3H, s), 4.2 (1H, m), 5.3 (2H, s), 5.9 (1H, d), 6.9-8.2 (8H, m) 83 1H-NMR (CDCl3, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s), 6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m) 85 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.8 (3H, s), 2.2 (3H, s), 2.6 (2H, dd), 4.2 (1H, m), 5.3 (2H, s), 6.5 (1H, d), 6.9 (1H, s), 7.3-8.4 (7H, m) 89 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.7 (3H, s), 3.2 (2H, m), 4.5 (1H, m), 5.3 (2H, s), 6.6 (1H, d), 6.9-7.9 (8H, m) 94 1H-NMR (CDCl3, ppm): 1.57 (3H, s), 1.60 (3H, s), 2.20 (3H, s), 2.30 (3H, s), 2.93 (2H, dd), 5.43 (2H, s), 6.57 (1H, s), 6.90 (1H, s), 7.0-8.2 (7H, m) 96 1H-NMR (CDCl3, ppm): 1.63 (6H, s), 2.27 (3H, s), 2.50 (3H, s), 3.47 (2H, s), 5.30 (2H, s), 6.23 (1H, s), 6.57 (1H, s), 7.0-8.1 (8H, m) 97 1H-NMR (CDCl3, ppm): 1.27 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.63 (2H, m), 4.33 (1H, m), 5.37 (2H, s), 6.07 (1H, m), 6.60 (1H, s), 6.9-8.2 (8H, m) 99 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.27 (3H, s), 2.70 (3H, s), 3.0-3.5 (2H, m), 4.60 (1H, m), 5.37 (2H, s), 6.5-8.0 (10H, m) 103 1H-NMR (CDCl3, ppm): 1.27 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.60 (2H, m), 4.33 (1H, m), 5.20 (2H, s), 6.17 (1H, s), 6.47 (1H, t), 7.1-8.3 (8H, m) 107 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.60 (2H, m), 4.33 (1H, m), 5.20 (2H, s), 6.17 (1H, s), 6.47 (1H, t), 6.67 (1H, m), 7.0-8.1 (7H, m) 116 1H-NMR (CDCl3, ppm): 1.2 (3H, d), 1.9 (3H, s), 2.2 (3H, s), 2.6 (2H, dd), 4.2 (1H, m), 5.2 (2H, s), 6.4 (1H, d), 7.0-8.3 (9H, m) 149 1H-NMR (CDCl3, ppm): 1.34 (6H, s), 1.95 (3H, s), 2.33 (3H, s), 2.86 (2H, s), 5.48 (2H, s), 6.11 (1H, s), 7.56-7.00 (4H, m), 7.84-7.72 (1H, m), 8.23 (1H, d), 8.49 (1H, s) 153 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 2.05 (3H, s), 2.30 (3H, s), 2.61-2.53 (2H, m), 4.40-4.29 (1H, m), 5.44 (2H, s), 6.19 (1H, d), 7.17 (2H, t), 7.54-7.48 (2H, m), 7.73 (1H, d), 8.15 (1H, d), 8.44 (1H, s) 180 1H-NMR (CDCl3, ppm): 1.3 (3H, d), 2.2 (3H, s), 2.3 (3H, s), 2.8 (2H, d), 4.5 (1H, m), 5.4 (2H, s), 7.1-8.3 (8H, m) 242 1H-NMR (CDCl3, ppm): 1.4 (3H, d), 2.2 (3H, s), 2.8 (3H, s), 3.2 (2H, m), 4.6 (1H, m), 5.5 (2H, s), 6.2-8.2 (9H, m) 251 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.95 (3H, s), 2.28 (3H, s), 2.63-2.51 (2H, m), 3.28 (3H, s), 4.36-4.26 (1H, m), 5.43 (2H, s), 6.38 (1H, d, J = 9.3 Hz), 7.39-7.16 (2H, m), 7.62-7.53 (2H, m), 7.81-7.74 (1H, m), 8.38 (1H, s) 271 1H-NMR (CDCl3, ppm): 1.47 (6H, s), 2.00 (3H, s), 2.30 (3H, s), 2.83 (2H, s), 3.30 (1H, m), 4.2-4.6 (4H, m), 6.07 (1H, s), 7.1-8.2 (7H, m) 277 1H-NMR (CDCl3, ppm): 1.1 (6H, d), 2.2 (3H, s), 4.1 (1H, m), 5.0 (2H, s), 6.0 (1H, d), 7.0-8.4 (8H, m) 417 1H-NMR (CDCl3, ppm): 1.5 (3H, d), 2.3 (3H, s), 2.8 (3H, s), 3.2 (2H, dd), 4.7 (1H, m), 6.5 (1H, m), 7.0 (1H, s), 7.3-8.3 (6H, m) 422 1H-NMR (CDCl3, ppm): 1.47 (6H, s), 2.03 (3H, s), 2.40 (3H, s), 2.87 (2H, s), 6.03 (1H, s), 6.80 (1H, m), 7.1-8.6 (8H, m) 434 1H-NMR (CDCl3, ppm): 1.40 (6H, s), 2.03 (3H, s), 2.40 (3H, s), 2.87 (2H, s), 6.07 (1H, s), 6.77 (1H, m), 7.2-8.5 (8H, m) 521 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.90 (3H, s), 2.26 (3H, s), 2.50-2.67 (2H, m), 4.10-4.50 (1H, m), 5.37 (2H, s), 6.15 (1H, d), 6.60 (1H, bs), 6.90-7.20 (3H, m), 7.57 (1H, bs), 7.70 (1H, d), 7.80-8.23 (3H, m) 522 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.30 (3H, s), 2.70 (3H, s), 2.97-3.50 (2H, m), 4.56 (1H, m), 5.43 (2H, s), 6.60-8.03 (10H, m) 523 1H-NMR (CDCl3, ppm): 1.40 (6H, s), 1.98 (3H, s), 2.30 (3H, s), 2.73 (2H, s), 5.40 (2H, s), 6.03 (1H, bs), 6.60-7.20 (4H, m), 7.50-8.20 (5H, m) 529 1H-NMR (CDCl3, ppm): 1.42 (6H, s), 1.98 (3H, s), 2.30 (3H, s), 2.71 (2H, s), 5.30 (2H, s), 6.03 (1H, bs), 6.52 (1H, d), 7.03-7.35 (4H, m), 7.73 (1H, d), 7.93 (1H, d), 8.10-8.40 (2H, m) 530 1H-NMR (CDCl3, ppm): 1.63 (6H, s), 2.30 (3H, s), 2.57 (3H, s), 3.47 (2H, s), 5.30 (2H, s), 6.40 (1H, bs), 6.57 (1H, d), 7.03-8.17 (8H, m) 532 1H-NMR (CDCl3, ppm): 1.30 (4H, dd), 1.97 (3H, s), 2.28 (3H, s), 2.73-2.42 (2H, m), 4.37-4.28 (1H, m), 5.28 (2H, s), 6.42 (1H, d), 6.55 (1H, d), 7.09 (2H, t), 7.42-7.39 (2H, m), 7.51 (1H, d), 7.70 (1H, t), 8.02 (1H, d), 8.49 (1H, d) 534 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.93 (3H, s), 2.30 (3H, s), 2.50-2.66 (2H, m), 4.23-4.40 (1H, m), 5.32 (2H, s), 6.16 (1H, d), 6.54 (1H, d), 7.06 (1H, bs), 7.11 (1H, d), 7.22 (1H, t), 7.40 (1H, d), 7.78 (1H, d), 7.97 (1H, d), 8.17 (1H, d), 8.30 (1H, bs) 536 1H-NMR (CDCl3, ppm): 1.50 (3H, d), 2.28 (3H, s), 2.73 (3H, s), 2.97-3.50 (2H, m), 4.60 (1H, m), 5.30 (2H, s), 6.53 (1H, d), 6.73 (1H, d), 7.00-8.07(8H, m) 537 1H-NMR (CDCl3, ppm): 1.40(6H, s), 1.98 (3H, s), 2.31 (3H, s), 2.81 (2H, s), 5.32 (2H, s), 6.08 (1H, bs), 6.54 (1H, d), 7.04 (1H, bs) 7.11 (1H, d), 7.20 (1H, t), 7.38 (1H, d), 7.79 (1H, d), 7.96 (1H, d), 8.22 (1H, d), 8.38 (1H, bs) 538 1H-NMR (CDCl3, ppm): 1.66(6H, s), 2.30 (3H, s), 2.60 (3H, s), 3.52 (2H, s), 5.30 (2H, s), 6.47 (1H, bs), 6.57 (1H, d), 7.03-8.23 (8H, m) 550 1H-NMR (CDCl3, ppm): 1.48 (6H, d), 2.21 (3H, s), 2.48 (3H, s), 4.13 (1H, m), 5.42 (2H, s), 6.18(1H, d), 6.91 (1H, s), 7.1-7.6 (6H, m), 8.08 (1H, d) 552 1H-NMR (CDCl3, ppm): 1.17 (3H, d), 1.89 (3H, s), 2.29 (3H, s), 2.42 (1H, dd), 2.60 (1H, dd), 3.29 (3H, s), 4.24 (1H, m), 5.42 (2H, s), 6.41 (1H, d), 6.92 (1H, s), 7.1-7.2 (2H, m). 7.6-8.2 (5H, m) 553 1H-NMR (CDCl3, ppm): 1.21 (3H, d), 1.32 (3H, t), 1.95 (3H, s), 2.29 (3H, s), 2.51 (1H, dd), 2.60 (1H, dd), 3.00 (2H, q), 4.31 (1H, m), 5.41 (2H, s), 6.28 (1H, d), 6.91 (1H, s), 7.1-7.2 (2H, m), 7.4-7.6 (3H, m), 8.09 (1H, d), 8.34 (1H, s) 554 1H-NMR (CDCl3, ppm): 1.25 (5H, dd), 1.91 (3H, s), 2.29 (3H, s), 2.60-2.54 (2H, m), 4.32-4.27 (1H, m), 5.44 (2H, s), 6.40 (1H, d), 7.06 (2H, d, J = 7.5 Hz), 7.19-7.12 (1H, m), 7.71 (1H, d), 7.94-7.91 (1H, m), 8.08 (1H, d), 8.36 (1H, s) 569 1H-NMR (CDCl3, ppm): 8.50 (1H, m), 7.95 (1H, m), 7.79-7.49 (4H, m), 7.44-7.38 (1H, m), 7.22 (1H, m), 5.75 (1H, q), 4.38 (1H, m), 2.79 (2H, m), 2.29 (3H, s), 2.20 (3H, s), 2.00 (3H, d), 1.43-1.18 (3H, d) 574 1H-NMR (CDCl3, ppm): 1.31 (3H, d), 1.95 (3H, s), 2.30 (3H, s), 2.61-2.57 (2H, m), 4.37-4.27 (1H, m), 5.79-5.73 (1H, m), 6.48 (1H, d), 7.02 (1H, s), 7.25-7.21 (2H, m), 7.52-7.36 (3H, m), 7.84-7.69 (2H, m), 8.04 (1H, d), 8.50 (1H, s) 594 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 1.93 (3H, s), 2.26 (3H, s), 2.61-2.55 (2H, m), 4.36-4.27 (1H, m), 5.49 (2H, d), 6.07 (1H, d), 6.34-6.30 (1H, m), 6.98 (2H, d), 7.13 (1H, t), 7.27-7.22 (3H, m), 7.79 (1H, d), 7.97 (1H, dd), 8.08 (1H, d), 8.23 (1H, s) 595 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.94 (3H, s), 2.27 (3H, s), 2.60-2.54 (2H, m), 4.34-4.25 (1H, m), 5.49 (2H, d), 6.42 (1H, d), 7.04-6.99 (2H, m), 7.21-7.14 (2H, m), 7.35-7.32 (1H, m), 7.72 (1H, d), 7.93 (1H, dd), 8.05 (1H, d), 8.36 (1H, s) 596 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.97 (3H, s), 2.33 (3H, s), 2.63-2.54 (2H, m), 4.35-4.30 (1H, m), 5.52 (2H, s), 6.05 (1H, d), 7.02-7.00 (2H, m), 7.26-7.21 (1H, m), 7.35-7.32 (1H, m), 7.42-7.39 (1H, m), 7.80 (1H, t), 7.98 (1H, d), 8.18 (1H, t), 8.32 (1H, d) 626 1H-NMR (CDCl3, ppm): 1.22 (3H, d), 1.92 (3H, s), 2.30 (3H, s), 2.54 (1H, dd), 2.61 (1H, dd), 4.32 (1H, m), 5.46 (2H, s), 6.23 (1H, m), 6.94 (1H, s), 7.0-7.1 (2H, m), 7.45 (1H, m), 7.54 (1H, d), 7.72 (1H, d), 8.07 (1H, d), 8.38 (1H, bs) 632 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.96 (3H, s), 2.32 (3H, s), 2.61-2.55 (2H, m), 4.34-4.29 (1H, m), 5.22 (2H, s), 6.22 (1H, d), 7.21-7.13 (3H, m), 7.36 (1H, d), 7.78 (1H, d), 7.97 (1H, dd), 8.16 (1H, d), 8.35 (1H, s) 633 1H-NMR (CDCl3, ppm): 1.23 (3H, dd), 1.97 (3H, s), 2.31 (3H, s), 2.61-2.56 (2H, m), 4.37-4.32 (1H, m), 5.25 (2H, s), 6.13 (1H, d), 7.11 (2H, dd), 7.37 (1H, t), 7.48 (1H, dd), 7.61-7.53 (1H, m), 7.79 (1H, dt), 8.15 (1H, d), 8.43 (1H, d) 634 1H-NMR (CDCl3, ppm): 1.25 (4H, dd), 1.98 (3H, s), 2.33 (3H, s), 2.61-2.56 (2H, m), 8.41 (1H, s), 4.38-4.31 (1H, m), 5.24 (2H, s), 6.17 (1H, d), 7.13-7.11 (2H, m), 7.38 (1H, s), 7.46 (1H, t), 7.56 (1H, dd), 7.79 (1H, t), 8.14 (1H, d) 635 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.94 (3H, s), 2.31 (3H, s), 2.61-2.52 (2H, m), 4.33-4.29 (1H, m), 524 (2H, s), 6.34 (1H, d), 7.21-7.11 (3H, m), 7.39 (1H, d), 7.75 (1H, d), 7.95 (1H, dd), 8.13 (1H, d,)8.38 (1H, s) 636 1H-NMR (CDCl3, ppm): 1.25 (3H, dd), 1.93 (2H, s), 2.31 (3H, s), 2.65-2.52 (2H, m), 4.32-4.29 (1H, m), 5.26 (2H, s), 6.40 (1H, d), 7.21-7.11 (3H, m), 8.39 (1H, s), 7.42 (1H, s), 7.74 (1H, d), 7.94 (1H, d), 8.11 (1H, d) 640 1H-NMR (CDCl3, ppm): 1.29 (3H, dd), 1.95 (3H, s), 2.32 (3H, s), 2.62-2.54 (2H, m), 4.34-4.27 (1H, m), 5.31 (2H, s), 6.21 (1H, d), 7.96 (1H, d), 8.19 (1H, t), 7.21-7.13 (3H, m), 7.62 (1H, s), 7.78 (1H, d), 8.37 (1H, d) 651 1H-NMR (CDCl3, ppm): 1.24 (3H, dd), 1.96 (3H, s), 2.31 (3H, s), 2.60-2.55 (2H, m), 4.36-4.31 (1H, m), 5.31 (2H, s), 6.34 (1H, d), 7.16-7.14 (2H, m), 7.43 (1H, t), 7.53 (1H, dd), 7.64 (1H, s), 7.71 (1H, d), 8.12 (1H, d), 8.50 (1H, s) 654 1H-NMR (CDCl3, ppm): 1.26 (3H, dd), 1.93 (3H, s), 2.34 (3H, d), 2.62-2.55 (2H, m), 4.34-4.29 (1H, m), 5.31 (2H, s), 6.23 (1H, d), 7.24-7.14 (3H, m), 7.63 (1H, s), 7.78 (1H, d), 7.97 (1H, dd), 8.20 (1H, d), 8.37 (1H, s) 658 1H-NMR (CDCl3, ppm): 1.44-1.38 (3H, m), 2.35-2.30 (6H, m), 2.90-2.77 (2H, m), 4.56-4.48 (1H, m), 5.32 (2H, s), 7.18-7.14 (3H, m), 7.44-7.37 (1H, m), 7.56-7.52 (1H, m), 7.67-7.64 (2H, m), 8.10-8.07 (1H, m), 8.44-8.39 (1H, m) 660 1H-NMR (CDCl3, ppm): 1.25 (4H, dd), 1.90 (3H, s), 2.31 (3H, s), 2.63-2.55 (2H, m), 4.37-4.28 (1H, m), 5.34 (2H, s), 6.12 (1H, d), 7.22-7.15 (2H, m), 7.63 (1H, d), 7.83 (1H, t), 7.98 (1H, dt), 8.25 (1H, t), 8.34 (1H, s) 675 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.97 (3H, s), 2.33 (3H, s), 2.63-2.54 (2H, m), 4.38-4.29 (1H, m), 5.41 (2H, s), 6.21 (1H, d), 7.09 (2H, d), 7.44 (1H, t), 7.54 (1H, d), 7.73 (1H, d), 7.84 (1H, s), 8.07 (1H, d), 8.38 (1H, s) 681 1H-NMR (CDCl3, ppm): 1.25 (3H, d), 1.95 (3H, s), 2.32 (3H, s), 2.62-2.54 (2H, m), 4.36-4.32 (1H, m), 5.52 (2H, s), 6.13 (1H, d), 7.18-7.16 (2H, m), 7.57-7.47 (2H, m), 7.76 (1H, d), 8.17 (1H, d), 8.41 (1H, s) 714 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.99 (3H, s), 2.30 (3H, s), 2.64-2.52 (2H, m), 4.38-4.29 (1H, m), 5.49 (2H, s), 6.15 (1H, d), 7.17-7.15 (2H, m), 7.57-7.43 (2H, m), 7.75 (1H, d), 8.17 (1H, d), 8.41 (1H, s) 726 1H-NMR (CDCl3, ppm): 1.45-1.37 (3H, m), 2.32-2.30 (6H, m), 2.87-2.83 (2H, m), 4.61-4.46 (1H, m), 5.44 (2H, s), 6.90-6.88 (1H, m), 7.12-7.09 (2H, m), 7.45-7.42 (1H, m), 7.55-7.52 (1H, m), 7.68-7.66 (1H, m), 7.79-7.77 (1H, m), 8.06-8.04 (1H, m), 8.32-8.24 (1H, m) 727 1H-NMR (CDCl3, ppm): 1.44 (3H, d), 2.30 (3H, s), 2.75 (3H, s), 3.24-3.21 (2H, m), 4.62-4.53 (1H, m), 5.44 (2H, s), 6.87-6.85 (1H, m), 7.08-7.06 (2H, m), 7.42-7.32 (1H, m), 7.50-7.47 (1H, m), 7.60-7.57 (1H, m), 7.77 (1H, s), 7.91-7.87 (1H, m), 8.17-8.14 (1H, m) 729 1H-NMR (CDCl3, ppm): 1.45 (3H, d), 2.29 (3H, s), 2.75 (3H, s), 3.34-3.12 (2H, m), 4.59-4.54 (1H, m), 5.38 (2H, s), 6.86 (1H, d), 7.09-7.06 (2H, m), 7.43-7.33 (1H, m), 7.52-7.46 (1H, m), 7.59 (1H, d), 7.84 (1H, s), 7.90 (1H, d), 8.15 (1H, s) 730 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.96 (3H, s), 2.29 (3H, s), 2.5-2.7 (2H, m), 4.31 (1H, m), 5.34 (2H, s), 6.31 (1H, d), 6.4-7.2 (5H, s), 7.4-7.8 (3H, m), 8.06 (1H, d), 8.41 (1H, bs) 741 1H-NMR (CDCl3, ppm): 1.26 (3H, d), 1.95 (3H, s), 2.18 (3H, s), 2.30 (3H, s), 2.66-2.48 (2H, m), 4.39-4.20 (1H, m), 5.31 (2H, s), 6.25 (1H, d), 7.07-7.01 (2H, m), 7.44-7.41 (2H, m), 7.55-7.51 (2H, m), 7.71 (1H, d), 8.01 (1H, d), 8.32 (1H, s) 778 1H-NMR (CDCl3, ppm): 1.31 (3H, d), 1.95 (3H, s), 2.33 (3H, t), 2.61-2.56 (2H, m), 4.40-4.29 (1H, m), 5.28 (2H, s), 6.50-6.11 (2H, m), 7.15-7.12 (2H, m), 7.45-7.42 (1H, m), 7.55-7.52 (1H, m), 7.64 (1H, s), 7.72 (1H, d), 8.12 (1H, d), 8.50 (1H, s) 799 1H-NMR (CDCl3, ppm): 1.23 (3H, d), 1.93 (3H, s), 2.32 (3H, s), 2.56 (2H, m), 4.22 (1H, m), 5.52 (2H, s), 6.55-6.02 (3H, m), 7.21 (2H, m), 7.57-7.43 (2H, m), 7.76 (1H, d), 8.15 (1H, d), 8.39 (1H, s) 1H-NMR (CDCl3, ppm): 1.24 (3H, d), 1.94 (3H, s), 2.28 (3H, s), 2.52 (1H, dd), 2.62 (1H, dd), 4.30 (1H, m), 5.38 (2H, s), 6.4-7.2 (7H, m), 7.72 (1H, d), 7.93 (1H, d), 8.06 (1H, d), 8.41 (1H, bs) 1H-NMR (CDCl3, ppm): 1.40 (6H, s), 1.93 (3H, s), 2.77 (2H, s), 5.40 (2H, s), 5.93 (1H, bs), 6.87-7.23 (4H, m), 7.63-7.95 (2H, m), 8.35-8.65 (2H, m)

Synthesis Example 6 Starting material

3-Methyl-4-nitrobenzyl chloride (1.81 g), 3,5-bis(trifluoromethyl)-1H-pyrazole (2.0 g) and potassium carbonate (1.63 g) were stirred in DMF (20 ml) at 60° C. for 1 hour. After finishing the reaction, water (100 ml) was added thereto and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride (100 ml) and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-3,5-bis-(trifluoromethyl)-1H-pyrazole (3.3 g).

¹H-NMR (CDCl₃, ppm): 2.59 (3H, s), 5.50 (2H, s), 6.90 (1H, s), 7.1-7.2 (2H, m), 8.00 (1H, d).

Synthesis Example 7 Starting Material

To a mixture of 1-(3-methyl-4-nitrobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (1.4 g), ammonium acetate (30.5 g), acetone (60 ml) and water (30 ml), 20% aqueous solution of titanium trichloride (27.5 g) was added at room temperature and the mixture was stirred at room temperature for 12 hours. After finishing the reaction, the mixture was extracted with ethyl acetate, washed with saturated aqueous solution of sodium chloride and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (1.19 g).

¹H-NMR (CDCl₃, ppm): 2.14 (3H, s), 3.66 (2H, m), 5.32 (2H, s), 6.62 (1H, d), 6.89 (1H, s), 6.8-7.1 (2H, m).

Synthesis Example 8 Starting material

1-(3-Methyl-4-nitrobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (17.66 g) and iron powder (13.69 g) were heated and stirred in acetic acid (150 ml) at 40° C. for 5 hours. After finishing the reaction, an insoluble matter was filtered with Celite and the filtrate was concentrated under the reduced pressure. To the residue, 1N aqueous solution of sodium hydrate (200 ml) and ethyl acetate (200 ml) were added. The organic layer was separated, washed with water, and then, dried with anhydrous magnesium sulfate. After distilling off the solvent, 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (13.0 g), which was the same as that obtained in Synthesis Example 7, was obtained.

Synthesis Example 9 Starting Material

3-Fluorophthalic anhydride (4.98 g) and 1-(3-methyl-4-aminobenzyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (9.70 g) were refluxed in acetic acid (43 ml) for 3 hours. After finishing the reaction, the acetic acid was distilled off wader the reduced pressure and the obtained crude crystals were washed with t-butyl methyl ether to obtain the aimed 2-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-ylmethyl]-2-methylphenyl}-4-fluoroisoindol-1,3-dione (10.80 g). mp. 158-159° C.

Synthesis Example 10 Starting Material

3-Methyl-4-nitrobenzyl chloride (0.56 g), 5-(difluoromethyl)-1,2-dihydro-2-methyl-3H-1,2,4-(triazol)-3-one (0.45 g) and potassium carbonate (0.61 g) were stirred in DMF (10 ml) at 50° C. for 5 hours. After finishing the reaction, the reaction mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride and then dried with anhydrous magnesium sulfate, and the solvent was distilled off under the reduced pressure. The obtained residue was purified by silica gel column chromatography to obtain the aimed 5-difluoromethyl-2-methyl-4-(3-methyl-4-nitrobenzyl)-2,4-dihydro-[1,2,4]triazol-3-one (0.45 g).

¹H-NMR (CDCl₃, ppm): 2.5 (3H, s), 3.5 (3H, s), 4.9 (2H, s), 6.4 (1H, t), 72-7.3 (2H, m), 7.8-7.9 (1H, m).

Synthesis Example 11 Starting Material

3-Methyl-nitrobenzyl chloride (0.43 g), 3-heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole (0.70 g), tetrabutylammonium iodide (0.09 g), 18-crown-6 (0.06 g) and potassium carbonate (0.48 g) were refluxed in acetonitrile (10 ml) for 2 hours. After cooling, the reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 3-hepta fluoropropylsulfanyl-1-(3-methyl-4-nitrobenzyl)-5-trifluoromethyl-1H-(1,2,4)-triazole (0.30 g).

¹H-NMR (CDCl₃, ppm): 2.64 (3H, s), 5.62 (2H, s), 7.31-7.25 (2H, m), 8.05-7.86 (1H, m)

Synthesis Example 12 Starting Material

To a mixture of 3-heptafluoropropylsulfanyl-1-(3-methyl-4-nitrophenyl)-5-trifluoromethyl-1H-(1,2,4)-triazole (0.3 g), ammonium acetate (4.8 g), acetone (20 ml) and water (10 ml), 20% aqueous solution of titanium trichloride (4.3 g) was added at room temperature and the mixture was stirred at room temperature for 12 hours. After finishing the reaction, the mixture was extracted with ethyl acetate, washed with saturated aqueous solution of sodium chloride and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 4-(3-heptafluoropropylsulfanyl-5-trifluoromethyl-[1,2,4]triazol-1-ylmethyl)-2-methyl-phenylamine (0.28 g)

¹H-NMR (CDCl₃, ppm): 2.17 (3H, s), 4.16 (1H, brs), 5.40 (2H, s), 6.63-6.59 (2H, m), 7.13-6.99 (1H, m).

Synthesis Example 13 Starting Material

An acetonitrile solution (30 ml) of 3-trifluoromethyl-1H-pyrazole (5.0 g), dicerium ammonium nitrate (10.0 g) and iodine (5.6 g) was refluxed for 1 hour. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-3-trifluoromethyl-1H-pyrazole (93 g).

¹H-NMR (CDCl₃, ppm): 7.77 (1H, s).

Synthesis Example 14 Starting Material

3-Methyl-4-nitrobenzyl chloride (0.77 g), 4-iodo-3-trifluoromethyl-1H-pyrazole (0.99 g) and potassium carbonate (0.63 g) were stirred in DMF (10 ml) at 60° C. for 1 hour. After cooling, the reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (1.0 g).

¹H-NMR (CDCl₃, ppm): 2.62 (3H, s), 5.36 (2H, s), 7.21-7.18 (2H, m), 7.52 (1H, s), 7.98 (1H, d).

Synthesis Example 15 Starting Material

4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.06 g), copper powder (0.95 g), iodopentafluoroethane (4.92 g) and DMF (13 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate (50 ml) and an insoluble matter was filtered with Celite and washed with ethyl acetate. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-pentafluoroethyl-3-trifluoromethyl-1H-pyrazole (1.39 g)

¹H-NMR (CDCl₃, ppm): 2.63 (3H, s), 5.38 (2H, s), 7.21-7.27 (2H, m), 7.74 (1H, s), 8.00 (1H, d).

Synthesis Example 16 Starting Material

3-Methyl-4-nitrobenzyl chloride (8.57 g), 4-iodo-3-pentafluoroethyl-1H-pyrazole (16.00 g) and potassium carbonate (7.66 g) were stirred in DMF (70 ml) at 70° C. for 1 hour. After cooling, the reaction solution was poured into water and extracted with ethyl acetate. The organic phase was washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (4.60 g).

¹H-NMR (CDCl₃, ppm): 2.60 (3H, s), 5.38 (2H, s), 7.22-7.15 (2H, m), 7.53 (1H, s), 7.98 (1H, d).

Synthesis Example 17 Starting Material

4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (1.84 g), (trifluoromethyl)trimethylsilane (1.14 g), copper(I) iodide (1.52 g), potassium fluoride (0.28 g) were stirred in DMF (8 ml) at 100° C. for 8 hours. After cooling, the mixture was poured into water and extracted with ethyl acetate. The combined organic phase was washed with saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitro-benzyl)-3-pentafluoroethyl-4-trifluoromethyl-1H-pyrazole (0.32 g).

¹H-NMR (CDCl₃, ppm): 2.61 (3H, s), 5.41 (2H, s), 7.31-7.18 (2H, m), 7.78 (1H, s), 8.00 (1H, d).

Synthesis Example 18 Starting Material

4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.06 g), copper powder (0.95 g), heptafluoro-1-iodopropane (2.96 g) and DMF (14 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with ethyl acetate (50 ml) and an insoluble matter was filtered with Celite and washed with ethyl acetate. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-pentafluoropropyl-3-trifluoromethyl-1H-pyrazole (0.80 g).

¹H-NMR (CDCl₃, ppm): 2.62 (3H, s), 5.42 (2H, s), 7.19-7.20 (2H, m), 7.74 (1H, s), 8.02 (1H, d).

Synthesis Example 19 Starting Material

4-Iodo-1-(3-methyl-4-nitrobenzyl)-3-trifluoromethyl-1H-pyrazole (2.47 g), copper powder (1.14 g), nonafluoro-1-iodobutane (4.15 g) and DMF (16 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 130-135° C. After cooling to room temperature, the reaction mixture was diluted with toluene (50 ml) and an insoluble matter was filtered with Celite and washed with toluene. The filtrate was concentrated under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-nonafluorobutyl-3-trifluoromethyl-1H-pyrazole (1.50 g).

¹H-NMR (CDCl₃, ppm): 2.62 (3H, s), 5.42 (2H, s), 7.18-7.24 (2H, m), 7.74 (1H, s), 8.00 (1H, d).

Synthesis Example 20 Starting Material

An acetonitrile solution (20 ml) of 3-trifluoromethyl-1H-pyrazole (1.0 g), dicerium ammonium nitrate (2.0 g) and bromine (0.7 g) was refluxed for 2 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-bromo-3-trifluoromethyl-1H-pyrazole (1.6 g).

¹H-NMR (CDCl₃, ppm): 7.73 (1H, s), 12.86 (1H, brs).

Synthesis Example 21 Starting Material

3-Methyl-4-nitrobenzyl chloride (0.77 g), 4-bromo-3-trifluoromethyl-1H-pyrazole (0.90 g) and potassium carbonate (0.57 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-bromo-3-trifluoromethyl-1H-pyrazole (0.9 g).

¹H-NMR (CDCl₃, ppm): 2.58 (3H, s), 5.35 (2H, s), 7.24-7.21 (2H, m), 7.49 (1H, s), 7.98 (1H, d).

Synthesis Example 22 Starting Material

An acetonitrile solution (20 ml) of 3-trifluoromethyl-1H-pyrazole (0.5 g), dicerium ammonium nitrate (1.0 g) and N-chlorosuccinimide (0.7 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying an organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-chloro-3-trifluoromethyl-1H-pyrazole (0.9 g).

¹H-NMR (CDCl₃, ppm): 7.80 (1H, s).

Synthesis Example 23 Starting Material

3-Methyl-4-nitrobenzyl chloride (0.82 g), 4-chloro-3-trifluoromethyl-1H-pyrazole (0.63 g) and potassium carbonate (0.61 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-4-chloro-3-trifluoromethyl-1H-pyrazole (0.98 g).

¹H-NMR (CDCl₃, ppm): 2.62 (3H, s), 5.33 (2H, s), 7.21-7.19 (2H, m), 7.46 (1H, s), 7.98 (1H, d).

Synthesis Example 24 Starting Material

2-(Trifluoroacetyl)-1H-pyrrole (0.97 g) was added to DMF solution (10 ml) of 60% sodium hydride (0.16 g) and the mixture was stirred at room temperature for 30 mutes. 3-Methyl-4-nitrobenzyl chloride (1.0 g) was added thereto and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrobenzyl)-2-(trifluoroacetyl)-1H pyrrole (1.53 g).

¹H-NMR (CDCl₃, ppm): 2.55 (3H, s), 5.59 (2H, s), 6.44-6.41 (1H, m), 6.99 (1H, d), 7.04 (1H, s), 7.22-7.19 (1H, m), 7.35-7.32 (1H, m), 7.93 (1H, d).

Synthesis Example 25 Starting Material

An acetonitrile solution (20 ml) of 2-(trifluoroacetyl)-1H pyrrole (0.5 g), dicerium ammonium nitrate (0.84 g) and iodine (0.47 g) was refluxed for 2 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-2-(trifluoroacetyl)-1H pyrrole (0.6 g).

¹H-NMR (CDCl₃, ppm): 7.28-7.35 (2H, m), 9.52 (1H, brs).

Synthesis Example 26 Starting Material

3-Methyl-4-nitrobenzyl chloride (0.63 g), 4-iodo-2-(trifluoroacetyl)pyrrole (0.89 g) and potassium carbonate (0.57 g) were stirred in DMF (10 ml) at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 4-iodo-1-(3-methyl-4-nitrobenzyl)-2-trifluoroacetyl-1H-pyrrole (0.45 g).

¹H-NMR (CDCl₃, ppm): 2.60 (3H, s), 5.56 (2H, s), 7.05-7.12 (2H, m), 7.21 (1H, d), 7.39 (1H, s), 7.94 (1H, d).

Synthesis Example 27 Starting Material

4-Iodo-1-(3-methyl-4-nitrobenzyl)-2-trifluoroacetyl-1H-pyrrole (1.75 g), copper powder (5.08 g), iodopentafluoroethane (5.92 g) and DMSO (6 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120° C. After finishing the reaction, the reaction mixture was poured into ice water and an insoluble matter was filtered with Celite, and then, it was extracted with ethyl acetate. The extracted solution was washed with water and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-4-pentafluoroethyl-1H-pyrrole (1.35 g).

¹H-NMR (CDCl₃, ppm): 2.59 (3H, s), 5.62 (2H, s), 7.00-7.10 (2H, m), 7.43-7.50 (2H, m), 7.96 (1H, d).

Some specific examples of other processes to synthesize the compounds of the aforementioned formula (IX) are shown below.

Synthesis Example 28 Starting Material

To a toluene suspension of ethyl 4,4,4-trifluoroacetoacetate (5.0 g), sodium hydride (1.1 g) was slowly added and the mixture was stirred for 1 hour. After adding 4-chloromethyl-2-methyl-1-nitro-benzene (5.5 g) and potassium iodide dissolved in acetone (0.5 g), the reaction solution was refluxed for 5 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain ethyl 4,4,4-trifluoro-2-(3-methyl-4-nitro-benzyl)-3-oxo-butyrate (6.3 g). n_(D) ²⁰ 1.4970

Synthesis Example 29 Starting Material

Ethyl 4,4,4-trifluoro-2-(3-methyl-4-nitro benzyl)-3-oxo-butyrate (2.0 g), hydrazine monohydrate (0.5 g) and a small amount of p-toluenesulfonic acid were dissolved in toluene, and the mixture was refluxed for 4 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-2,4-dihydro-pyrazol-3-one (1.0 g).

¹H-NMR (DMSO-d₆, 90 MHz): δ2.2 (3H, s), 3.8 (2H, s), 7.0 (1H, d, J=5.5 Hz), 7.2 (1H, s), 7.8 (1H, d, J=5.5 Hz), 11.2 (1H, brs).

Synthesis Example 30 Starting Material

To a DMF suspension of 4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-2,4-dihydro-pyrazol-3-one (1.0 g) and potassium carbonate (1.5 g), chlorodifluoromethane (5.7 g) was sealed in by using a balloon. After 5 hours, after the gas in the solution was saturated, the vessel was tightly closed and the mixture was stirred at 50° C. for 5 hours. After cooling, the solvent was distilled off and the obtained residue was dissolved in ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 5-difluoromethoxy-1-difluoromethyl-4-(3-methyl-4-nitro-benzyl)-3-trifluoromethyl-1H-pyrazole (IX-1) (0.5 g) and 3-difluoromethoxy-1-difluoromethyl-4-(3-methyl-4-nitro-benzyl)-5-trifluoromethyl-1H-pyrazole (IX-2) (0.4 g) respectively.

(IX-1): n_(D) ²⁰ 1.4780, (IX-2): n_(D) ²⁰ 1.4855.

Synthesis Example 31 Starting Material

(3-Methyl-4-nitrophenyl)-hydrazine (3.0 g) and hexafluoroacetylacetone (3.7 g) were dissolved in toluene and the solution was refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-3,5-bis(trifluoromethyl)-1H-pyrazole (5.6 g). n_(D) ²⁰ 1.4890.

Synthesis Example 32 Starting Material

(3-Methyl-4-nitro-phenyl)-hydrazine (2.0 g) and 1,1,1,5,5,6,6,6-octafluoro-2,4-hexanedione (3.1 g) were dissolved in toluene and the solution was refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitro-phenyl)-3-pentafluoroethyl-5-trifluoromethyl-1H-pyrazole (IX-3) (3.0 g) and 2-(3-methyl-nitro-phenyl)-5-pentafluoroethyl-3-trifluoromethyl-3,4-dihydro-2H-pyrazol-3-ol (IX-4) (0.5 g), respectively.

(IX-3): n_(D) ²⁰ 1.4690,

(IX-4): ¹H-NMR (CDCl₃, 90 MHz): δ2.6 (3H, s), 3.3 (1H, br d, J=16 Hz), 3.7 (1H, br d, J=16 Hz), 4.1 (1H, s), 7.2 (2H, m), 7.8 (1H, d, J=7.8 Hz).

Synthesis Example 33 Starting Material

To a THF suspension of 1-(3-methyl-4-nitro-phenyl)-ethanone (2.0 g), sodium hydride (0.6 g) was slowly added and the mixture was stirred for 1 hour. After adding ethyl trifluoroacetate (1.6 g), the reaction mixture was refluxed for 5 hours. After cooling, the solvent was distilled off under reduced pressure. The residue was suspended in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 4,4,4-trifluoro-1-(3-methyl-4-nitro-phenyl)-butane-1,3-dione (2.5 g).

¹H NMR (CDCl₃, 90 MHz): δ2.6 (3H, s), 6.5 (1H, s), 7.7-8.1 (3H, m).

Synthesis Example 34 Starting Material

A toluene solution of 4,4,4-trifluoro-1-(3-methyl-4-nitro-phenyl)-butane-1,3-dione (1.8 g), 2,2,2-trifluoroethylhydrazine (1.2 g) and a catalytic amount of p-toluenesulfonic acid were refluxed for 6 hours. After cooling, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 3-(3-methyl-4-nitro-phenyl)-1-(2,2,2-trifluoro-ethyl)-5-trifluoro-methyl-1H-pyrazole (IX-5) (1.1 g) and 5-(3-methyl-4-nitro phenyl)-1-(2,2,2-trifluoro-ethyl)-3-trifluoromethyl-1H-pyrazole (IX-6) (0.5 g), respectively.

(IX-5) mp; 98-104° C., (IX-6) mp; 50-53° C.

Synthesis Example 35 Starting Material

To a dichloromethane solution of 2,2-dimethyl-1,3-dioxane-4,6-dione (10 g) and dimethylaminopyridine (17 g), a dichloromethane solution of 3-methyl-4-nitro-benzoyl chloride (14 g) was added dropwise under ice cooling. After stirring at room temperature for 3 hours and then adding 100 ml of ethanol, the mixture was refluxed for 2 hours. After cooling, the solvent was distilled off under the reduced pressure. The residue was dissolved in ethyl acetate and washed with 1N aqueous solution of hydrochloric acid. After drying the organic layer with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain ethyl 3-(3-methyl-4-nitro-phenyl)-3-oxo-propionate (12.4 g). mp; 207-211° C.

Synthesis Example 36 Starting Material

To an ethanol solution of ethyl 3-(3-methyl-4-nitro-phenyl)-3-oxo propionate (3.0 g), hydrazine monohydrate (0.9 g) and a small amount of p-toluenesulfonic acid were added and the mixture was refluxed for 5 hours. After cooling, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 5-(3-methyl-4-nitro-phenyl)-2,4-dihydro-pyrazol-3-one (2.6 g). mp; 218-219° C.

Synthesis Example 37 Starting Material

To a DMF suspension of 5-(3-methyl-4-nitro-phenyl)-2,4-dihydro-1H-pyrazol-3-one (2.0 g) and potassium carbonate (6.3 g), chlorodifluoromethane (8.7 g) was sealed in by using a balloon. After 5 hours, after the gas in the solution was saturated, the vessel was tightly closed and the mixture was stirred at 50° C. for 5 hours. After cooling, the solvent was distilled off and the obtained residue was dissolved in ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying with sodium sulfate, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography to obtain 5-difluoromethoxy-1-difluoromethyl-3-(3-methyl-4-nitro-phenyl)-1H-pyrazole (IX-7) (0.7 g) and 3-difluoromethoxy-1-difluoromethyl-5-(3-methyl-4-nitro-phenyl)-1H-pyrazole (IX-8) (0.5 g), respectively.

(IX-7) rap; 80-82° C., (IX-8) mp; 99-100° C.

Synthesis Example 38 Starting Material

To an ethanol solution (60 ml) of hydrazine monohydrate (5.00 g), an ethanol solution (20 ml) of 3-methyl-4-nitrobenzyl chloride (3.71 g) was added dropwise while refluxing it, and the mixture was continuously refluxed for 6 hours. After finishing the reaction, the solvent was distilled off and (3-methyl-4-nitrobenzyl)-hydrazine (3.50 g) was obtained.

¹H-NMR (CDCl₃, ppm): 2.60 (3H, s), 2.65-3.35 (3H, m), 3.95 (2H, s), 7.20-7.40 (2H, m), 7.98 (1H, d).

Synthesis Example 39 Starting Material

(3-Methyl-4-nitrobenzyl)-hydrazine (1.81 g) and 5-ethoxy-1,1,1,2,2-pentafluoro-4-penten-3-one (2.18 g) were refluxed in ethanol (60 ml) for 8 hours, and p-toluenesulfonic acid (0.10 g) was added thereto and the mixture was further refluxed for 6 hours. After finishing the reaction, the solvent was distilled off and the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain 1-(3-methyl-4-nitrobenzyl)-5-pentafluoroethyl-1H-pyrazole (0.96 g) as the first elution portion and 1-(3-methyl-4-nitrobenzyl)-3-pentafluoroethyl-1H-pyrazole (0.50 g) as the second elution portion.

(IX-9): ¹H-NMR (CDCl₃, ppm): 2.61 (3H, s), 5.49 (2H, s), 6.70 (1H, bs), 7.05-7.15 (2H, m), 7.66 (1H, bs), 7.94 (1H, d).

(IX-10): ¹H-NMR (CDCl₃, ppm): 2.64 (3H, s), 5.40 (2H, s), 6.63 (1H, d), 7.07-7.20 (2H, m), 7.52 (1H, d), 7.95 (1H, d).

Synthesis Example 40 Starting Material

A mixture of 5-fluoro-2-nitrotoluene (2.33 g), 4-iodo-1H-pyrazole (2.91 g) and potassium carbonate (2.49 g) was heated and stirred in DMF (30 ml) at 140° C. for 4 hours. After cooling to room temperature, the reaction mixture was poured into ice water to separate out crystals. The obtained crystals were filtered, washed with water and dried, and 4-iodo-1-(3-methyl-4-nitrophenyl)-1H-pyrazole (4.60 g) was obtained.

¹H-NMR (CDCl₃, ppm): 2.70 (3H, s), 7.50-7.70 (3H, m), 7.95-8.15 (2H, m).

Synthesis Example 41 Starting Material

4-Iodo-1-(3-methyl-4-nitrophenyl)-1H-pyrazole (1.98 g), copper powder (1.14 g), iodopentafluoroethane (8.85 g) and DMSO (9 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 100° C. After finishing the reaction, the reaction mixture was poured into ice water and an insoluble matter was filtered with Celite, and then, it was extracted with ethyl acetate. The extracted solution was washed with water and dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-(3-methyl-4-nitrophenyl)-4-pentafluoroethyl-1H-pyrazole (0.72 g).

¹H-NMR (CDCl₃, ppm): 2.70 (3H, s), 7.60-7.73 (2H, m), 7.93 (1H, s), 8.13 (1H, d), 8.23 (1H, s).

Synthesis Example 42 Starting Material

To a suspension of methanol (300 ml) of 3-methyl-4-nitroacetophenone (26.88 g), sodium borohydride (8.51 g) was added at 0° C. over a period of 1 hour. The mixture was further stirred at room temperature for 8 hours. After finishing the reaction, the reaction mixture was poured into ice water (1,000 ml) and extracted with ether. The organic layer was washed with saturated aqueous solution of sodium chloride and dried with anhydrous magnesium sulfate. After distilling off the solvent, the aimed 1-(3-methyl-4-nitrophenyl)-ethanol (23.33 g) was obtained.

¹H-NMR (CDCl₃, ppm): 1.51 (3H, d), 1.98 (1H, d), 2.62 (3H, s), 4.90-5.01 (1H, m), 7.28-7.35 (2H, m), 7.98 (1H, d).

Synthesis Example 43 Starting Material

Into a THF solution (35 ml) of 1-(3-methyl-4-nitrophenyl)-ethanol (5.44 g) and triethylamine (3.95 g), a THF solution (10 ml) of methanesulfonyl chloride (3.48 g) was added dropwise at 5° C. over a period of 30 minutes. Further, the mixture was stirred at room temperature for 8 hours. After finishing the reaction, the solvent was distilled off and the residue was dissolved in ethyl acetate (100 ml). It was washed with 2N aqueous solution of hydrochloric acid and saturated aqueous solution of sodium bicarbonate and then dried with anhydrous magnesium sulfate. After distilling off the solvent, the aimed 1-(3-methyl-4-nitrophenyl)-ethyl methanesulfonate (5.80 g) was obtained.

¹H-NMR (CDCl₃, ppm): 1.74 (3H, d), 2.65 (3H, s), 2.95 (3H, s), 5.76 (1H, q), 7.35-7.45 (2H, m), 8.01 (1H, d).

Synthesis Example 44 Starting Material

1-(3-Methyl-4-nitrophenyl)-ethyl methanesulfonate (2.59 g), 3-trifluoromethyl-1H-pyrazole (1.09 g), potassium carbonate (1.66 g) and 18-crown-6 (0.26 g) were refluxed in acetonitrile (100 ml) for 6 hours. After finishing the reaction, water (100 ml) was added to the mixture and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium bicarbonate and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography to obtain 1-[1-(3-methyl-4-nitrophenyl)-ethyl]-3-trifluoromethyl-1H-pyrazole (1.60 g).

¹H-NMR (CDCl₃, ppm): 1.95 (3H, d), 2.59 (3H, s), 5.59 (1H, q), 6.57 (1H, bs), 7.13-7.20 (2H, m), 7.47 (1H, bs), 8.00 (1H, d).

Synthesis Example 45 Starting Material

Ethyl pentafluoropropylenate (14.6 g) and hydrazine monohydrate (3.6 g) were refluxed in tetrahydrofuran (300 ml) for 1 hour. After cooling to room temperature, trifluoroacetamidine (10.0 g) was added dropwise to the mixture and it was refluxed for 3 hours. After finishing the reaction, saturated aqueous solution of sodium hydrogen carbonate was added thereto and the mixture was extracted with ethyl acetate. After drying the organic layer with anhydrous magnesium sulfate, the solvent was distilled off to obtain crude 3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (7.9 g).

Synthesis Example 46 Starting Material

1-(3-Methyl-4-nitrophenyl)-ethyl methanesulfonate (2.5 g), 3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (2.2 g), potassium carbonate (1.6 g) and 18-crown-6 (0.26 g) were refluxed in acetonitrile (100 mil) for 6 hours. After finishing the reaction, water (100 ml) was added thereto and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride (100 ml) and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain (IX-11) 1-([1-(3-methyl-4-nitro phenyl)-ethyl]-5-pentafluoroethyl-3-trifluoromethyl-1H-(1,2,4)-triazole (0.95 g) as the first elution portion and (IX-12) 1-([1-(3-methyl-4-nitro-phenyl)-ethyl]-3-pentafluoroethyl-5-trifluoromethyl-1H-(1,2,4)-triazole (1.35 g) as the second elution portion.

(IX-11)

¹H-NMR (CDCl₃) δ: 8.03-7.97 (1H, m), 7.37 (2H, t, J=5.4 Hz), 5.86 (1H, q, J=7.0 Hz), 2.62 (3H, s), 2.00 (3H, d, J=7.0 Hz).

(IX-12)

¹H-NMR (CDCl₃) δ: 7.98 (1H, d; J=8.2 Hz), 7.34 (2H, t, J=7.1 Hz), 5.81 (1H, q, J=7.0 Hz), 2.63 (3H, s), 2.01 (3H, d, J=7.0 Hz).

Synthesis Example 47 Starting Material

Sodium hydride (0.10 g) was added to a DMF solution (12 ml) of 4-methyl-5-pentafluoroethyl-4H-[1,2,4]triazol-3-thiol (0.70 g), and the mixture was stirred at room temperature until the generation of hydrogen gas stopped. Continuously, 5-fluoro-2-nitrotoluene (0.47 g) was added thereto and the mixture was further stirred at room temperature for 1 hour. After cooling to room temperature, the reaction mixture was poured into ice water and extracted with ethyl acetate. The organic layer was washed with saturated aqueous solution of sodium chloride and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained residue was purified by silica gel column chromatography (mixed solvent of n-hexane and ethyl acetate) to obtain the aimed 4-methyl-3-(3-methyl-4-nitrophenyl sulfanyl)-5-pentafluoroethyl-4H-(1,2,4)-triazole (0.55 g).

¹H-NMR (CDCl₃, ppm): 2.70 (3H, s), 3.80 (3H, s), 8.10-8.30 (3H, m).

Synthesis Example 48 Starting Material

A mixture of 2-methylmelcapto-4.6-bistrifluoromethyl-pyrimidine (36 g), oxone (126 g), water (500 ml) and chloroform (110 ml) was refluxed for 2 days. After cooling to room temperature, the mixture was extracted with dichloromethane. The obtained organic layer was washed with water and then dried with anhydrous sodium sulfate. After distilling off the solvent, the obtained crude crystals were washed with petroleum ether to obtain 2-methanesulfonyl-4.6-bistrifluoromethyl-pyrimidine (7.5 g).

¹H-NMR (CDCl₃, ppm): 3.48 (3H, s), 8.19 (1H, s).

Synthesis Example 49 Starting Material

4-Nitro-m-cresol (0.77 g), 2-methanesulfonyl-4,6-bistrifluoromethyl-pyrimidine (1.77 g) and potassium carbonate (1.04 g) were refluxed in acetonitrile (15 ml) for 5 hours. After finishing the reaction, the reaction mixture was poured into ice to separate out crystals. The obtained crystals were filtered and dried to obtain 2-(3-methyl-4-nitrophenoxy)-4,6-bistrifluoromethyl-pyrimidine (1.03 g).

¹H-NMR (CDCl₃, ppm): 2.60 (3H, s), 7.1-7.3 (2H, m), 7.67 (1H, s), 8.10 (1H, d).

Synthesis Example 50 Starting Material

(3-Methyl-4-nitrophenyl)-acetonitrile (3.52 g) was dissolved in pyridine (30 ml), thereto excess H₂S was bubbled into at room temperature for 3 hours. Then the mixture was poured onto ice. The precipitate was collected by suction, washed with water and dried to obtain 2-(3-methyl-4-nitro-phenyl)-thioacetamide (1.69 g).

¹H-NMR (CDCl₃, ppm): 2.60 (3H, s), 4.06 (2H, s), 6.40-8.00 (5H, m)

Synthesis Example 51 Starting Material

2-(3-Methyl-4-nitrophenyl)-thioacetamide (1.00 g), 1-bromo-3,3,4,4,4-pentafluoro-2-butanone (1.15 g) and potassium carbonate (0.79 g) were stirred in DMF (10 ml) at room temperature for 1 hour. The reaction solution was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 2-(3-Methyl-4-nitro-phenyl)-thioacetimidic acid 3,3,4,4,4-pentafluoro-2-oxo-butyl ester (1.30 g).

¹H-NMR (CDCl₃, ppm): 2.55 (3H, s), 3.57 (2H, dd), 3.90 (2H, d), 7.24-7.22 (2H, m), 7.91-7.89 (1H, m)

Synthesis Example 52 Starting Material

Trifluoroacetic anhydride (1.47 g) was added to 2-(3-Methyl-4-nitro-phenyl)-thioacetimidic acid 3,3,4,4,4-pentafluoro ester (130 g) and triethylamine (0.71 g) in dichloromethane (10 ml), and stirred at room temperature for 20 minutes. The reaction solution was washed with water, and the solvent was distilled off under the reduced pressure and the obtained residue was purified by silica gel column chromatography to obtain 2-(3-methyl-4-nitro-benzyl)-4-perfluoroethyl-thiazole (0.70 g).

¹H-NMR (CDCl₃, ppm): 2.63 (3H, s), 4.43 (2H, s), 7.30-7.28 (2H, m), 7.75 (1H, s), 7.98 (1H, d)

Synthesis Example 53 Starting Material

An acetonitrile solution (20 ml) of 3-pentafluoroethyl-1H-pyrazole (2.0 g), dicerium ammonium nitrate (3.0 g) and iodine (1.6 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 4-iodo-3-pentafluoroethyl-1H-pyrazole (32 g).

¹H-NMR (CDCl₃, ppm): 7.77 (1H, s), 11.11 (1H, m)

Synthesis Example 54 Starting Material

4-Iodo-3-pentafluoroethyl-1H-pyrazole (6.24 g), copper powder (3.81 g), Iodo-1,1,2,2-tetrafluoroethane (9.12 g) and DMF (30 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120-125° C. After cooling to room temperature, the insoluble material was filtered off through Celite and washed with diethyl ether. The filtrate was diluted with water and extracted with diethyl ether. The organic phase was washed with water and dried over sodium sulfate, and concentrated under the reduced pressure. The crude product was distilled under reduced pressure to obtain 3-pentafluoroethyl-4-(1,1,2,2-tetrafluoroethyl)-1H-pyrazole (0.60 g), bp. 125-135° C./20 mbar.

¹H-NMR (CDCl₃, ppm): 5.98 (1H, tt), 7.96 (1H, s), 12.22 (1H, m)

Synthesis Example 55 Starting Material

4-Iodo-3-pentafluoroethyl-1H-pyrazole (12.48 g), copper powder (7.63 g), iodopentafluoroethane (29.50 g) and DMF (60 ml) were set in an autoclave and heated and stirred for 8 hours, maintaining the inside temperature of 120-125° C. After cooling to room temperature, the insoluble material was filtered off through Celite and washed with diethyl ether. The filtrate was diluted with water and extracted with diethyl ether. The organic phase was washed with water and dried over sodium sulfate, and concentrated under the reduced pressure. The crude product was distilled under reduced pressure to obtain 3,4-bis-pentafluoroethyl-1H-pyrazole (1.20 g), bp. 110-115° C./20 mbar.

¹H-NMR (CDCl₃, ppm): 7.99 (1H, s), 12.31 (1H, m).

Synthesis Example 56 Starting Material

An acetonitrile solution (20 ml) of 4-methyl-1H-pyrazole (0.5 g), dicerium ammonium nitrate (1.7 g) and iodine (1.9 g) was refluxed for 3 hours. After cooling, the reaction solution was washed with saturated aqueous solution of sodium thiosulfate and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 3,5-diiodo-4-methyl-1H-pyrazole (1.2 g).

¹H-NMR (CDCl₃, ppm): 2.03 (3H, s), 6.96 (1H, br s)

Synthesis Example 57 Starting Material

5-Trifluoromethyl-1H-(1,2,4)-triazole-3-thiol (1.0 g), heptafluoro-1-iodopropane (3.5 g) and triethylamine (0.90 g) were stirred in DMF (10 ml) at 90° C. for 24 hours. After cooling to room temperature; the reaction mixture was diluted with ethyl acetate and washed with water and saturated aqueous solution of sodium chloride. After drying the organic layer with magnesium sulfate, the solvent was distilled off under the reduced pressure to obtain 3-heptafluoropropylsulfanyl-5-trifluoromethyl-1H-(1,2,4)-triazole (0.70 g).

USE EXAMPLES Biological Test Example 1 Test Against Larva of Spodoptera litura Preparation of Test Solution:

Solvent: Dimethylformamide: 3 parts by weight Emulsifier: Polyoxyethylene alkyl phenyl ether: 1 part by weight

In order to make an appropriate formulation of an active compound, 1 part by weight of the active compound was mixed with the above-mentioned amount of solvent containing the above-mentioned amount of emulsifier and the mixture was diluted with water to a prescribed concentration.

Test Method:

Leaves of sweet potato were soaked in the test solution diluted to a prescribed concentration with water, dried in the air and put in a dish of 9 cm diameter.

10 larvae of Spodoptera litura at the third instar were placed on the leaves and kept in a room at the constant temperature of 25° C. After 2 and 4 days further leaves of sweet potato were added and after 7 days the number of dead larvae was counted and the rate of death was calculated.

In this test the results of 2 dishes at 1 section were averaged.

Biological Test Example 2 Test Against Larva of Cnaphalocrocis medinalis Guenee Test Method:

Paddy rice (variety: Tamanishiki) planted in a pot was treated by spraying 50 ml per pot of the diluted aqueous solution of the prescribed concentration of the active compound prepared in the same manner as in the above-mentioned Biological Test Example 1. After the treated rice plant was dried in the air, their foliage part was cut in 4-5 cm length, which were put in a dish with 9 cm diameter with a sheet of filter paper and 2 ml of water. Five larvae of Cnaphalocrocis medinalis Guenee at the second instar were put in the dish that was placed in a room at the constant temperature of 25° C. After 2 and 4 days; each rest (each ⅓ amount) of foliage parts of rice plant were cut in the same manner and added to the dish. After 7 days the number of dead larvae was counted and the rate of death was calculated. In this test the results of 2 dishes at 1 section were averaged.

Test Results:

In the above Biological Test Examples 1 and 2, as specific examples, the compounds of the aforementioned compound Nos. 8, 9, 10, 11, 12, 13, 14, 15, 16, 45, 47, 48, 49, 51, 52, 53, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 93, 103, 107, 116, 128, 132, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 153, 155, 157, 174, 176, 177, 178, 180, 181, 182, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 226, 227, 229, 230, 231, 238, 239, 242, 243, 251, 253, 262, 264, 268, 270, 281, 299, 308, 310, 318, 322, 413, 414, 417, 422, 434, 446, 448, 473, 475, 492, 506, 508, 512, 518, 520, 539, 543, 544, 545, 546, 547, 548, 549, 552, 554, 559, 561, 562, 563, 564, 565, 566, 567, 568, 570, 571, 572, 573, 574, 578, 579, 580, 626, 637, 638, 639, 640, 641, 642, 643, 644, 645, 646, 647, 648, 649, 650, 655, 656, 657, 658, 659, 660, 661, 662, 663, 664, 665, 666, 667, 668, 669, 670, 671, 672, 681, 761, 762, 763, 804 and 920 showed controlling effect of 100% of rate of death at 20 ppm concentration of the active component.

Biological Test Example 3 Test Against Myzus persicae Resistant to Organophosphorous Agents and Carbamates Test Method:

About 30 bred Myzus persicae resistant to organophosphorous agents and carbamates were inoculated per 1 seedling of eggplant planted in a vinyl pot of 6 cm diameter. One day after the inoculation, a sufficient amount of a diluted aqueous solution of a prescribed concentration of an active compound prepared as mentioned above, was sprayed by using a spray gun. After spraying it was placed in a green house of 28° C. and the rate of death was calculated 7 days after the spraying. Test was repeated twice.

Test Results

The compounds of the aforementioned compound Nos. 140, 141, 144, 146, 147, 148, 174, 176, 177, 178, 180, 181, 211, 213, 214, 215, 218, 220, 222, 226, 239, 243, 569, 570, 572, 579, 761, 797 and 920 offered to the test as specific examples showed controlling effect of 100% of rate of death at 100 ppm concentration of the effective component.

Formulation Example 1 Granule

To a mixture of 10 parts of the compound of the present invention (No. 8), 30 parts of bentonite (montmorillonite), 58 parts of talc and 2 parts of ligninsulfonate salt, 25 parts of water are added, well kneaded, made into granules of 10-40 mesh by an extrusion granulator and dried at 40-50° C. to obtain granules.

Formulation Example 2 Granules

95 Parts of clay mineral particles having particle diameter distribution in the range of 0.2-2 mm are put in a rotary mixer. While rotating it, 5 parts of the compound of the present invention (No. 11) are sprayed together with a liquid diluent, wetted uniformly and dried at 40-50° C. to obtain granules.

Formulation Example 3 Emulsifiable Concentrate

30 Parts of the compound of the present invention (No. 12), 55 parts of xylene, 8 parts of polyoxyethylene alkyl phenyl ether and 7 parts of calcium alkylbenzenesulfonate are mixed and stirred to obtain an emulsifiable concentrate.

Formulation Example 4 Wettable Powder

15 Parts of the compound of the present invention (No. 15), 80 parts of a mixture of white carbon (hydrous amorphous silicon oxide fine powders) and powder clay (1:5), 2 parts of sodium alkylbenzenesulfonate and 3 parts of sodium alkylnaphthalenesulfonate-formalin-condensate are crushed and mixed to make a wettable powder.

Formulation Example 5 Water Dispersible Granule

20 Parts of the compound of the present invention (No. 16), 30 parts of sodium ligninsulfonate, 15 parts of bentonite and 35 parts of calcined diatomaceous earth powder are well mixed, added with water, extruded with 0.3 mm screen and dried to obtain water dispersible granules. 

1-3. (canceled)
 4. A process for the preparation of a compound of formula (I),

wherein X represents hydrogen, halogen, nitro, C₁₋₆alkylsulfonyloxy, C₁₋₆alkylsulfinyl, C₁₋₆alkylsulfenyl or C₁₋₆alkylsulfonyl, R¹ represents C₁₋₆alkyl, C₁₋₆alkylthio-C₁₋₆alkyl, C₁₋₆alkylsulfinyl-C₁₋₆alkyl or C₁₋₆alkylsulfonyl-C₁₋₆alkyl, Y represents halogen or C₁₋₆alkyl, m represents 0 or 1, A represents O, S, SO, SO₂, CH₂ or CH(CH₃), and Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted; comprising (a) reacting a compound of formula (II)

wherein R¹ and X have the same definition as above, with a compound of formula (III)

wherein Y, A, m and Q have the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or (b) reacting a compound of formula (IV)

wherein X, Y, A, m and Q have the same definitions as above with a compound of formula (V) H₂N—R¹  (V) wherein R¹ has the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or (c) reacting a compound of formula (VI)

wherein X and R¹ have the same definitions as above, with a compound of formula (III),

wherein Y, A, m and Q have the same definition as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or (d) reacting a compound of formula (VII)

wherein X, Y, A, m and Q have the same definitions as above, with a compound of formula (V), H₂N—R¹  (V) wherein R¹ has the same definitions as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or (e) reacting a compound of formula (VIII)

wherein X, Y, A, m and Q have the same definitions as above, with a compound of formula (V), H₂N—R¹  (V) wherein R¹ has the same definitions as above, in the presence of an inert solvent, and optionally in the presence of an acid catalyst, or (f) in case where R¹ represents C₁₋₆alkylsulfinyl-C₁₋₆alkyl or C₁₋₆alkylsulfonyl-C₁₋₆alkyl in formula (I): reacting a compound of formula (If)

wherein R^(If) represents C₁₋₆alkylthio-C₁₋₆alkyl, and X, Y, A, m and Q have the same definitions as above, with an oxidizing agent in the presence of an inert solvent. 5-9. (canceled)
 10. A compound of formula (VII)

wherein X represents hydrogen, halogen, nitro, C₁₋₆alkylsulfonyloxy, C₁₋₆alkylsulfinyl, C₁₋₆alkylsulfenyl or C₁₋₆alkylsulfonyl, Y represents halogen or C₁₋₆alkyl, A represents O, S, SO, SO₂, CH₂ or CH(CH₃), m represents 0 or 1, and Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted.
 11. (canceled)
 12. A compound of formula (IX)

wherein X represents hydrogen, halogen, nitro, C₁₋₆alkylsulfonyloxy, C₁₋₆alkylsulfinyl, C₁₋₆alkylsulfenyl or C₁₋₆alkylsulfonyl, Y represents halogen or C₁₋₆alkyl, A represents O, S, SO, SO₂, CH₂ or CH(CH₃), m represents 0 or 1, and Q represents a 5-membered or 6-membered heterocyclic group that contains at least one hetero atom selected from the group consisting of N, O and S and can be optionally substituted. 